Cover
Cover | 9 Months Ended |
Sep. 30, 2022 shares | |
Cover [Abstract] | |
Document Type | 10-Q |
Amendment Flag | false |
Document Quarterly Report | true |
Document Transition Report | false |
Document Period End Date | Sep. 30, 2022 |
Document Fiscal Period Focus | Q3 |
Document Fiscal Year Focus | 2022 |
Current Fiscal Year End Date | --12-31 |
Entity File Number | 333-168195 |
Entity Registrant Name | FIRSTHAND TECHNOLOGY VALUE FUND, INC. |
Entity Central Index Key | 0001495584 |
Entity Tax Identification Number | 27-3008946 |
Entity Incorporation, State or Country Code | MD |
Entity Address, Address Line One | 150 Almaden Boulevard |
Entity Address, Address Line Two | Suite 1250 |
Entity Address, City or Town | San Jose |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 95113 |
City Area Code | (408) |
Local Phone Number | 886-7096 |
Entity Current Reporting Status | Yes |
Entity Interactive Data Current | Yes |
Entity Filer Category | Non-accelerated Filer |
Entity Small Business | false |
Entity Emerging Growth Company | false |
Entity Shell Company | false |
Entity Common Stock, Shares Outstanding | 6,893,056 |
Consolidated Statements of Asse
Consolidated Statements of Assets and Liabilities (Unaudited) - USD ($) | Sep. 30, 2022 | Dec. 31, 2021 | |
Investment securities: | |||
Unaffiliated investments at acquisition cost | [1] | $ 2,242,833 | $ 1,729,653 |
Affiliated investments at acquisition cost | 662,235 | 4,744,427 | |
Controlled investments at acquisition cost | 138,855,562 | 138,754,479 | |
Total acquisition cost | 141,760,630 | 145,228,559 | |
Unaffiliated investments at market value | [1] | 1,242,833 | 1,009,813 |
Affiliated investments at market value | 379,650 | 613,650 | |
Controlled investments at market value | 44,981,416 | 89,505,079 | |
Total Market value* (Note 6) | [2] | 46,603,899 | 91,128,542 |
Foreign currency at value (cost $3,215 and $0) | 3,198 | ||
Receivable from dividends and interest | 1,178,043 | 11,485,642 | |
Other assets | 20,313 | 64,066 | |
Total Assets | 47,805,453 | 102,678,250 | |
LIABILITIES | |||
Due to Custodian | 13,589 | ||
Payable for securities purchased | 1,876 | ||
Payable to affiliates (Note 4) | 8,936,422 | 7,702,914 | |
Trustees’ fees payable | 50,000 | ||
Consulting fee payable | 49,000 | 26,000 | |
Accrued expenses and other payables | 333,530 | 181,123 | |
Total Liabilities | 9,370,828 | 7,923,626 | |
NET ASSETS | 38,434,625 | 94,754,624 | |
Net Assets consist of: | |||
Common Stock, par value $0.001 per share 100,000,000 shares authorized | 6,893 | 6,893 | |
Paid-in-capital | 176,770,722 | 176,770,722 | |
Total distributable earnings (loss) | (138,342,990) | (82,022,991) | |
Shares of Common Stock outstanding | $ 7,016,432 | $ 7,016,432 | |
Shares of Treasury Stock outstanding | (123,376) | (123,376) | |
Total Shares of Common Stock outstanding | 6,893,056 | 6,893,056 | |
Net asset value per share (Note 2) | $ 5.58 | $ 13.75 | |
[1]Includes Fidelity Investment Money Market Treasury Portfolio - Class I, which invests primarily in U.S. Treasury securities. The yields as of 09/30/22 and 12/31/21 were 2.82% and 0.01%, respectively. Please see https://fundresearch.fidelity.com/mutual-funds/summary/316175504 for additional information.[2]Includes warrants whose primary risk exposure is equity contracts. |
Consolidated Statements of As_2
Consolidated Statements of Assets and Liabilities (Unaudited) (Parenthetical) - USD ($) | Sep. 30, 2022 | Dec. 31, 2021 |
Consolidated Statements Of Assets And Liabilities Unaudited | ||
Foreign currency cost | $ 3,215 | $ 0 |
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Consolidated Statements of Oper
Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | ||
INVESTMENT INCOME | |||||
Unaffiliated interest | $ 7,715 | $ 2,599 | $ (2,765) | $ 28,297 | |
Affiliated/controlled interest | (8,307,960) | 1,546,351 | (10,174,101) | 4,213,345 | |
TOTAL INVESTMENT INCOME | (8,300,245) | 1,548,910 | (10,176,866) | 4,241,642 | |
Investment advisory fees (Note 4) | 268,873 | 555,311 | 1,144,669 | 1,694,468 | |
Administration fees | 30,366 | 30,622 | 88,293 | 91,190 | |
Custody fees | 3,105 | 7,585 | 17,220 | 20,681 | |
Transfer agent fees | 18,195 | 13,005 | 30,592 | 30,225 | |
Registration and filing fees | 8,520 | 8,242 | 25,281 | 24,458 | |
Professional fees | 94,567 | 101,564 | 280,272 | 271,083 | |
Printing fees | 17,136 | 18,541 | 62,079 | 53,997 | |
Trustees fees | 50,000 | 50,000 | 150,000 | 150,000 | |
Compliance fees | 29,938 | 30,355 | 88,838 | 87,559 | |
Miscellaneous fees | 23,024 | 15,098 | 69,491 | 37,651 | |
TOTAL GROSS EXPENSES | 543,724 | 830,323 | 1,956,735 | 2,461,312 | |
NET INVESTMENT INCOME | (8,843,969) | 718,587 | (12,133,601) | 1,780,330 | |
Net realized gains (losses) from security transactions on: | |||||
Affiliated/Controlled | 1,798,143 | (3,131,579) | 4,548,597 | ||
Foreign currency | (51) | 1,895 | 27 | ||
Net realized gains (Losses) | 1,798,092 | (3,129,684) | 4,548,624 | ||
Net change in unrealized appreciation (depreciation) on: | |||||
Non-affiliated investments | (384,274) | (201,009) | (280,160) | (500,826) | |
Affiliated/controlled investments and foreign currency | (5,123,844) | (9,086,301) | (41,446,072) | (9,721,304) | |
Affiliated/controlled warrants investments | [1] | 1,192,425 | (5,840) | 669,518 | 519,140 |
Net change in unrealized appreciation (depreciation) | (4,315,693) | (9,293,150) | (41,056,714) | (9,702,990) | |
Net Realized and Unrealized Gains (Losses) on Investments | (2,517,601) | (9,293,150) | (44,186,398) | (5,154,366) | |
Net Increase (Decrease) In Net Assets Resulting From Operations | $ (11,361,570) | $ (8,574,563) | $ (56,319,999) | $ (3,374,036) | |
Net Increase (Decrease) In Net Assets Per Share Resulting From Operations | [2] | $ (1.65) | $ (1.24) | $ (8.17) | $ (0.49) |
[1]Primary exposure is equity risk.[2]Per share results are calculated based on weighted average shares outstanding for each period. |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||||
Net increase (decrease) in Net Assets resulting from operations | $ (11,361,570) | $ (8,574,563) | $ (56,319,999) | $ (3,374,036) |
Adjustments to reconcile net increase (decrease) in Net Assets derived from operations to net cash provided by (used in) operating activities | ||||
Purchases of investments | (2,734) | (2,734) | (13,512,264) | |
Proceeds from disposition of investments | 1,807,112 | 500,000 | 5,309,159 | 22,338,729 |
Net purchases/sales from short-term investments | (1,586,077) | (359,338) | (4,968,180) | (8,383,742) |
Increase (decrease) in dividends, interest, and reclaims receivable | 8,304,329 | (1,448,015) | 10,307,599 | (3,952,062) |
Increase (decrease) in due to Custodian | 1 | (13,589) | 13,151 | |
Increase (decrease) in payable for investment purchased | 1,876 | 1,876 | ||
Increase (decrease) in payable to affiliates | 298,811 | 496,584 | 1,233,508 | 1,692,945 |
Increase (decrease) in other assets | 26,134 | 12,019 | 43,753 | 9,445 |
Increase (decrease) in accrued expenses and other payables | (2,284) | 80,162 | 225,407 | 12,739 |
Net realized gain (loss) from investments | (1,798,092) | 3,129,684 | (4,548,624) | |
Net unrealized appreciation (depreciation) from investments, other assets, and warrants transactions | 4,315,693 | 9,293,150 | 41,056,714 | 9,702,990 |
Net cash provided by (used in) operating activities | 3,198 | 3,198 | (729) | |
CASH FLOWS FROM FINANCING ACTIVITIES | ||||
Net cash provided by financing activities | ||||
Net increase (decrease) in cash | 3,198 | 3,198 | (729) | |
Cash and foreign currency - beginning of period | 729 | |||
Cash and foreign currency - end of period | $ 3,198 | $ 3,198 |
Consolidated Statements of Chan
Consolidated Statements of Changes in Net Assets (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
FROM OPERATIONS: | ||||
Net investment income (loss) | $ (8,843,969) | $ 718,587 | $ (12,133,601) | $ 1,780,330 |
Net realized gain (loss) from security transactions, foreign currency and warrants transactions | 1,798,092 | (3,129,684) | 4,548,624 | |
Net change in unrealized (depreciation) on investments, other assets, and warrants transactions | (4,315,693) | (9,293,150) | (41,056,714) | (9,702,990) |
Net decrease in net assets from operations | (11,361,570) | (8,574,563) | (56,319,999) | (3,374,036) |
TOTAL DECREASE IN NET ASSETS | (11,361,570) | (8,574,563) | (56,319,999) | (3,374,036) |
NET ASSETS: | ||||
Beginning of period | 49,796,195 | 107,342,895 | 94,754,624 | 102,142,368 |
End of period | $ 38,434,625 | $ 98,768,332 | $ 38,434,625 | $ 98,768,332 |
COMMON STOCK ACTIVITY: | ||||
Shares outstanding, beginning of period | 6,893,056 | 6,893,056 | 6,893,056 | 6,893,056 |
Shares outstanding, end of period | 6,893,056 | 6,893,056 | 6,893,056 | 6,893,056 |
Consolidated Financial Highligh
Consolidated Financial Highlights - USD ($) $ in Thousands | 9 Months Ended | 12 Months Ended | |||||||||||
Sep. 30, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017 | ||||||||
Fair Value Disclosures [Abstract] | |||||||||||||
Net asset value at beginning of period | $ 13.75 | $ 14.82 | $ 17.70 | $ 26.69 | $ 23.83 | $ 20.04 | |||||||
Income from investment operations: | |||||||||||||
Net investment income (loss), before deferred taxes | (1.76) | 0.44 | [1] | 0.09 | [1] | 0.90 | [1] | (1.29) | [1] | (0.62) | |||
Deferred tax benefit | (0.08) | 0.07 | |||||||||||
Net investment gain (losses) | (1.76) | 0.44 | 0.09 | 0.82 | (1.22) | (0.62) | |||||||
Net realized and unrealized gains (losses) on investments, before deferred taxes | (6.41) | (1.51) | (2.30) | (12.15) | 5.13 | 4.21 | |||||||
Deferred tax expense | (1.13) | 2.34 | (1.23) | ||||||||||
Net realized and unrealized gains (losses) on investments, after deferred taxes | (6.41) | (1.51) | (3.43) | (9.81) | 3.90 | 4.21 | |||||||
Total from investment operations | (8.17) | (1.07) | (3.34) | (8.99) | 2.68 | 3.59 | |||||||
Realized capital gains | (0.03) | ||||||||||||
Anti-dilutive effect from capital share transactions | 0.46 | 0.21 | 0.20 | ||||||||||
Net asset value at end of period | 5.58 | 13.75 | 14.82 | 17.70 | 26.69 | 23.83 | |||||||
Market value at end of period | $ 1.34 | $ 4.01 | $ 4.47 | $ 6.43 | $ 11.20 | $ 8.96 | |||||||
Based on Net Asset Value | (59.42%) | [2] | (7.22%) | (16.27%) | (33.68%) | 12.39% | 18.91% | ||||||
Based on Market Value | (66.58%) | [2] | (10.29%) | (30.48%) | (42.59%) | 25.43% | 16.82% | ||||||
Net assets at end of period (millions) | $ 38,400 | $ 94,800 | $ 102,100 | $ 127,100 | $ 191,600 | $ 174,000 | |||||||
Ratio of total expenses to average net assets: | |||||||||||||
Before tax (benefit)/expense | 3.86% | [3] | 3.12% | 3.10% | (2.84%) | [4] | 6.75% | [4] | 4.13% | [4] | |||
Deferred tax (benefit)/expense | [5],[6] | 8.02% | [7] | (9.91%) | 4.43% | ||||||||
Total expenses | 3.86% | [3] | 3.12% | 11.12% | (12.75%) | [4] | 11.18% | [4] | 4.13% | ||||
Total expenses, excluding incentive fees and deferred tax expense | 3.86% | [3] | 3.12% | 3.10% | 2.80% | 2.77% | 2.98% | ||||||
Ratio of net investment income (loss) to average net assets: | |||||||||||||
Before tax benefit | (23.94%) | [3] | 2.94% | 0.64% | 3.93% | [4] | (4.93%) | [4] | (3.07%) | ||||
Deferred tax benefit | [6],[8] | (0.33%) | 0.28% | ||||||||||
Net investment income (loss) | (23.94%) | 2.94% | 0.64% | 3.60% | (4.65%) | (3.07%) | |||||||
Portfolio turnover rate | 0% | [2] | 16% | 13% | 18% | 44% | 22% | ||||||
[1]Calculated using average shares outstanding.[2]Not Annualized.[3]Annualized.[4]Amount includes the incentive fee. For the years ended December 31, 2019, December 31, 2018 and December 31, 2017 the ratio of the incentive fee to average net assets was (5.64)%, 3.98% and 1.15% respectively.[5]Deferred tax expense estimate is derived from net investment income (loss), and realized and unrealized gains (losses).[6]The deferred tax expense and tax benefit are based on average net assets.[7]As restated to reflect the removal of parenthetical notation to appropriately present ratio as deferred tax expense.[8]Deferred tax benefit estimate for the ratio calculation is derived from net investment income (loss) only. |
Consolidated Schedule of Invest
Consolidated Schedule of Investments - USD ($) | 9 Months Ended | 12 Months Ended | |||
Sep. 30, 2022 | Dec. 31, 2021 | ||||
Net Investment Income [Line Items] | |||||
VALUE | $ 42,408,025 | $ 59,744,294 | |||
VALUE | 46,603,899 | ||||
LIABILITIES IN EXCESS OF OTHER ASSETS | (8,169,274) | ||||
Net assets | $ 38,434,625 | 94,754,624 | |||
Total investment cost | 91,128,542 | ||||
Other assets in excess liabilities | $ 3,626,082 | ||||
Eqx Capital Inc [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Common Stock *(1)(2)(4) | [1],[2],[3],[4] | Common Stock *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Jun. 10, 2016 | Jun. 10, 2016 | |||
SHARES/PAR VALUE | 100,000 | 100,000 | |||
COST BASIS | $ 20,000 | $ 20,000 | |||
VALUE | $ 16,220 | $ 31,490 | |||
Equipment Leasing [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[3],[4] | Preferred Stock - Series A *(1)(2)(4) | |||
SHARES/PAR VALUE | 2,200,000 | ||||
COST BASIS | $ 2,200,000 | ||||
VALUE | $ 1,183,820 | ||||
ACQUISITION DATE | 6/10/16-11/7/16 | ||||
Eqx Capital Inc 1 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [5],[6],[7],[8] | Preferred Stock - Series A *(1)(2)(4) | |||
SHARES/PAR VALUE | 2,300,000 | ||||
COST BASIS | $ 2,300,000 | ||||
VALUE | $ 1,200,040 | $ 1,898,420 | |||
ACQUISITION DATE | 6/10/16 - 11/7/16 | ||||
Hera Systems Inc [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | May 31, 2018 | May 31, 2018 | |||
SHARES/PAR VALUE | 500,000 | 500,000 | |||
COST BASIS | $ 500,000 | $ 500,000 | |||
VALUE | $ 500,000 | $ 500,000 | |||
Hera Systems Inc 1 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Jan. 19, 2018 | Jan. 19, 2018 | |||
SHARES/PAR VALUE | 500,000 | 500,000 | |||
COST BASIS | $ 500,000 | $ 500,000 | |||
VALUE | $ 500,000 | $ 500,000 | |||
Hera Systems Inc 2 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Mar. 23, 2020 | Mar. 23, 2020 | |||
SHARES/PAR VALUE | 250,000 | 250,000 | |||
COST BASIS | $ 250,000 | $ 250,000 | |||
VALUE | $ 250,000 | $ 250,000 | |||
Hera Systems Inc 3 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Jun. 26, 2020 | Jun. 26, 2020 | |||
SHARES/PAR VALUE | 200,000 | 200,000 | |||
COST BASIS | $ 200,000 | $ 200,000 | |||
VALUE | $ 200,000 | $ 200,000 | |||
Hera Systems Inc 4 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Apr. 29, 2020 | Apr. 29, 2020 | |||
SHARES/PAR VALUE | 40,000 | 40,000 | |||
COST BASIS | $ 40,000 | $ 40,000 | |||
VALUE | $ 40,000 | $ 40,000 | |||
Hera Systems Inc 5 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | May 29, 2020 | May 29, 2020 | |||
SHARES/PAR VALUE | 20,000 | 20,000 | |||
COST BASIS | $ 20,000 | $ 20,000 | |||
VALUE | $ 20,000 | $ 20,000 | |||
Hera Systems Inc 6 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Aug. 06, 2020 | Aug. 06, 2020 | |||
SHARES/PAR VALUE | 220,000 | 220,000 | |||
COST BASIS | $ 220,000 | $ 220,000 | |||
VALUE | $ 220,000 | $ 220,000 | |||
Hera Systems Inc 7 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Sep. 10, 2020 | Sep. 10, 2020 | |||
SHARES/PAR VALUE | 150,000 | 150,000 | |||
COST BASIS | $ 150,000 | $ 150,000 | |||
VALUE | $ 150,000 | $ 150,000 | |||
Hera Systems Inc 8 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Oct. 08, 2020 | Oct. 08, 2020 | |||
SHARES/PAR VALUE | 250,000 | 250,000 | |||
COST BASIS | $ 250,000 | $ 250,000 | |||
VALUE | $ 250,000 | $ 250,000 | |||
Hera Systems Inc 9 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Nov. 17, 2020 | Nov. 17, 2020 | |||
SHARES/PAR VALUE | 250,000 | 250,000 | |||
COST BASIS | $ 250,000 | $ 250,000 | |||
VALUE | $ 250,000 | $ 250,000 | |||
Hera Systems Inc 10 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Dec. 21, 2020 | Dec. 21, 2020 | |||
SHARES/PAR VALUE | 250,000 | 250,000 | |||
COST BASIS | $ 250,000 | $ 250,000 | |||
VALUE | $ 250,000 | $ 250,000 | |||
Hera Systems Inc 11 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Jan. 26, 2021 | Jan. 26, 2021 | |||
SHARES/PAR VALUE | 50,000 | 50,000 | |||
COST BASIS | $ 50,000 | $ 50,000 | |||
VALUE | $ 50,000 | $ 50,000 | |||
Hera Systems Inc 12 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Feb. 16, 2021 | Feb. 16, 2021 | |||
SHARES/PAR VALUE | 150,000 | 150,000 | |||
COST BASIS | $ 150,000 | $ 150,000 | |||
VALUE | $ 150,000 | $ 150,000 | |||
Hera Systems Inc 13 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Mar. 25, 2021 | Mar. 25, 2021 | |||
SHARES/PAR VALUE | 150,000 | 150,000 | |||
COST BASIS | $ 150,000 | $ 150,000 | |||
VALUE | $ 150,000 | $ 150,000 | |||
Hera Systems Inc 14 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Apr. 27, 2021 | Apr. 27, 2021 | |||
SHARES/PAR VALUE | 150,000 | 150,000 | |||
COST BASIS | $ 150,000 | $ 150,000 | |||
VALUE | $ 150,000 | $ 150,000 | |||
Hera Systems Inc 15 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | May 24, 2021 | May 24, 2021 | |||
SHARES/PAR VALUE | 150,000 | 150,000 | |||
COST BASIS | $ 150,000 | $ 150,000 | |||
VALUE | $ 150,000 | $ 150,000 | |||
Hera Systems Inc 16 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Jun. 29, 2021 | Jun. 29, 2021 | |||
SHARES/PAR VALUE | 200,000 | 200,000 | |||
COST BASIS | $ 200,000 | $ 200,000 | |||
VALUE | $ 200,000 | $ 200,000 | |||
Hera Systems Inc 17 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Jul. 26, 2021 | Jul. 26, 2021 | |||
SHARES/PAR VALUE | 150,000 | 150,000 | |||
COST BASIS | $ 150,000 | $ 150,000 | |||
VALUE | $ 150,000 | $ 150,000 | |||
Hera Systems Inc 18 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Aug. 26, 2021 | Aug. 26, 2021 | |||
SHARES/PAR VALUE | 150,000 | 150,000 | |||
COST BASIS | $ 150,000 | $ 150,000 | |||
VALUE | $ 150,000 | $ 150,000 | |||
Hera Systems Inc 19 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Oct. 05, 2021 | Oct. 05, 2021 | |||
SHARES/PAR VALUE | 150,000 | 150,000 | |||
COST BASIS | $ 150,000 | $ 150,000 | |||
VALUE | $ 150,000 | $ 150,000 | |||
Hera Systems Inc 20 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Oct. 22, 2021 | Oct. 22, 2021 | |||
SHARES/PAR VALUE | 150,000 | 150,000 | |||
COST BASIS | $ 150,000 | $ 150,000 | |||
VALUE | $ 150,000 | $ 150,000 | |||
Hera Systems Inc 21 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Nov. 29, 2021 | Nov. 29, 2021 | |||
SHARES/PAR VALUE | 150,000 | 150,000 | |||
COST BASIS | $ 150,000 | $ 150,000 | |||
VALUE | $ 150,000 | $ 150,000 | |||
Hera Systems Inc 22 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Convertible Promissory Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Dec. 28, 2021 | Dec. 28, 2021 | |||
SHARES/PAR VALUE | 150,000 | 150,000 | |||
COST BASIS | $ 150,000 | $ 150,000 | |||
VALUE | $ 150,000 | $ 150,000 | |||
Hera Systems Inc 23 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Preferred Stock - Series A *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Feb. 10, 2022 | Sep. 18, 2015 | |||
SHARES/PAR VALUE | 150,000 | 3,642,324 | |||
COST BASIS | $ 150,000 | $ 2,000,000 | |||
VALUE | $ 150,000 | $ 8,377 | |||
Hera Systems Inc 24 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Preferred Stock - Series B *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Mar. 29, 2022 | ||||
SHARES/PAR VALUE | 90,000 | 7,039,203 | |||
COST BASIS | $ 90,000 | $ 6,587,102 | |||
VALUE | $ 90,000 | $ 229,478 | |||
ACQUISITION DATE | 8/7/17 - 2/1/19 | ||||
Hera Systems Inc 25 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Preferred Stock - Series C *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Mar. 11, 2022 | ||||
SHARES/PAR VALUE | 75,000 | 2,650,000 | |||
COST BASIS | $ 75,000 | $ 2,650,000 | |||
VALUE | $ 75,000 | $ 86,390 | |||
ACQUISITION DATE | 8/7/19-2/12/20 | ||||
Hera Systems Inc 26 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Preferred Stock Warrants - Series B *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Apr. 13, 2022 | ||||
SHARES/PAR VALUE | 70,000 | 12,250,000 | |||
COST BASIS | $ 70,000 | $ 0 | |||
VALUE | $ 70,000 | $ 398,738 | |||
ACQUISITION DATE | 7/9/18 - 9/4/18 | ||||
Hera Systems Inc 27 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Preferred Stock Warrants - Series B *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Apr. 26, 2022 | Feb. 01, 2019 | |||
SHARES/PAR VALUE | 75,000 | 5,250,000 | |||
COST BASIS | $ 75,000 | $ 0 | |||
VALUE | $ 75,000 | $ 170,888 | |||
Hera Systems Inc 28 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Preferred Stock Warrants - Series B *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | May 10, 2022 | Aug. 07, 2017 | |||
SHARES/PAR VALUE | 55,000 | 6,214,922 | |||
COST BASIS | $ 55,000 | $ 0 | |||
VALUE | $ 55,000 | $ 202,296 | |||
Hera Systems Inc 29 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | [1],[2],[4] | Preferred Stock Warrants - Series B *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | May 26, 2022 | Sep. 28, 2017 | |||
SHARES/PAR VALUE | 75,000 | 700,000 | |||
COST BASIS | $ 75,000 | $ 0 | |||
VALUE | $ 75,000 | 22,785 | |||
Hera Systems Inc 30 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | |||
ACQUISITION DATE | Jun. 10, 2022 | ||||
SHARES/PAR VALUE | 75,000 | ||||
COST BASIS | $ 75,000 | ||||
VALUE | $ 75,000 | $ 5,498,952 | |||
Hera Systems Inc 31 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | |||
ACQUISITION DATE | Jun. 28, 2022 | ||||
SHARES/PAR VALUE | 90,000 | ||||
COST BASIS | $ 90,000 | ||||
VALUE | $ 90,000 | ||||
Hera Systems Inc 32 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 10% (1)(2)(4) | |||
ACQUISITION DATE | Jul. 13, 2022 | ||||
SHARES/PAR VALUE | 100,000 | ||||
COST BASIS | $ 100,000 | ||||
VALUE | $ 100,000 | ||||
Hera Systems Inc 33 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[3],[4] | Preferred Stock - Series A *(1)(2)(4) | |||
ACQUISITION DATE | Sep. 18, 2015 | ||||
SHARES/PAR VALUE | 3,642,324 | ||||
COST BASIS | $ 2,000,000 | ||||
VALUE | $ 13,841 | ||||
Hera Systems Inc 34 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[3],[4] | Preferred Stock - Series B *(1)(2)(4) | |||
SHARES/PAR VALUE | 7,039,203 | ||||
COST BASIS | $ 6,587,102 | ||||
VALUE | $ 423,760 | ||||
ACQUISITION DATE | 8/7/17 - 2/1/19 | ||||
Hera Systems Inc 35 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[3],[4] | Preferred Stock - Series C *(1)(2)(4) | |||
SHARES/PAR VALUE | 2,650,000 | ||||
COST BASIS | $ 2,650,000 | ||||
VALUE | $ 159,530 | ||||
ACQUISITION DATE | 8/7/19-2/12/20 | ||||
Hera Systems Inc 36 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[3],[4] | Preferred Stock Warrants - Series B *(1)(2)(4) | |||
SHARES/PAR VALUE | 12,250,000 | ||||
COST BASIS | $ 0 | ||||
VALUE | $ 736,715 | ||||
ACQUISITION DATE | 7/9/18 - 9/4/18 | ||||
Hera Systems Inc 37 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[3],[4] | Preferred Stock Warrants - Series B *(1)(2)(4) | |||
ACQUISITION DATE | Feb. 01, 2019 | ||||
SHARES/PAR VALUE | 5,250,000 | ||||
COST BASIS | $ 0 | ||||
VALUE | $ 315,735 | ||||
Hera Systems Inc 38 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[3],[4] | Preferred Stock Warrants - Series B *(1)(2)(4) | |||
ACQUISITION DATE | Aug. 07, 2017 | ||||
SHARES/PAR VALUE | 6,214,922 | ||||
COST BASIS | $ 0 | ||||
VALUE | $ 373,765 | ||||
Hera Systems Inc 39 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[3],[4] | Preferred Stock Warrants - Series B *(1)(2)(4) | |||
ACQUISITION DATE | Sep. 28, 2017 | ||||
SHARES/PAR VALUE | 700,000 | ||||
COST BASIS | $ 0 | ||||
VALUE | 42,098 | ||||
Hera Systems Inc 40 [Member] | |||||
Net Investment Income [Line Items] | |||||
VALUE | $ 7,300,444 | ||||
Intraop Medical Corp [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Dec. 31, 2018 | Dec. 31, 2018 | |||
SHARES/PAR VALUE | 10,961,129 | 10,961,129 | |||
COST BASIS | $ 10,961,129 | $ 10,961,129 | |||
VALUE | $ 8,174,372 | $ 10,961,129 | |||
Intraop Medical Corp 1 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Jul. 12, 2019 | Jul. 12, 2019 | |||
SHARES/PAR VALUE | 1,300,000 | 1,300,000 | |||
COST BASIS | $ 1,300,000 | $ 1,300,000 | |||
VALUE | $ 969,488 | $ 1,300,000 | |||
Intraop Medical Corp 2 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Oct. 11, 2019 | Oct. 11, 2019 | |||
SHARES/PAR VALUE | 500,000 | 500,000 | |||
COST BASIS | $ 500,000 | $ 500,000 | |||
VALUE | $ 372,880 | $ 500,000 | |||
Intraop Medical Corp 3 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Oct. 29, 2019 | Oct. 29, 2019 | |||
SHARES/PAR VALUE | 500,000 | 500,000 | |||
COST BASIS | $ 500,000 | $ 500,000 | |||
VALUE | $ 372,880 | $ 500,000 | |||
Intraop Medical Corp 4 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Feb. 27, 2020 | Feb. 27, 2020 | |||
SHARES/PAR VALUE | 1,000,000 | 1,000,000 | |||
COST BASIS | $ 1,000,000 | $ 1,000,000 | |||
VALUE | $ 745,760 | $ 1,000,000 | |||
Intraop Medical Corp 5 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Mar. 25, 2020 | Mar. 25, 2020 | |||
SHARES/PAR VALUE | 500,000 | 500,000 | |||
COST BASIS | $ 500,000 | $ 500,000 | |||
VALUE | $ 372,880 | $ 500,000 | |||
Intraop Medical Corp 6 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | May 08, 2020 | May 08, 2020 | |||
SHARES/PAR VALUE | 400,000 | 400,000 | |||
COST BASIS | $ 400,000 | $ 400,000 | |||
VALUE | $ 298,304 | $ 400,000 | |||
Intraop Medical Corp 7 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Jul. 31, 2020 | Jul. 31, 2020 | |||
SHARES/PAR VALUE | 500,000 | 500,000 | |||
COST BASIS | $ 500,000 | $ 500,000 | |||
VALUE | $ 372,880 | $ 500,000 | |||
Intraop Medical Corp 8 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Aug. 28, 2020 | Aug. 28, 2020 | |||
SHARES/PAR VALUE | 750,000 | 750,000 | |||
COST BASIS | $ 750,000 | $ 750,000 | |||
VALUE | $ 559,320 | $ 750,000 | |||
Intraop Medical Corp 9 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Apr. 20, 2021 | Apr. 20, 2021 | |||
SHARES/PAR VALUE | 1,000,000 | 1,000,000 | |||
COST BASIS | $ 1,000,000 | $ 1,000,000 | |||
VALUE | $ 745,760 | $ 1,000,000 | |||
Intraop Medical Corp 10 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Jun. 10, 2021 | Jun. 10, 2021 | |||
SHARES/PAR VALUE | 500,000 | 500,000 | |||
COST BASIS | $ 500,000 | $ 500,000 | |||
VALUE | $ 372,880 | $ 500,000 | |||
Intraop Medical Corp 11 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Jul. 16, 2021 | Jul. 16, 2021 | |||
SHARES/PAR VALUE | 500,000 | 500,000 | |||
COST BASIS | $ 500,000 | $ 500,000 | |||
VALUE | $ 372,880 | $ 500,000 | |||
Intraop Medical Corp 12 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Sep. 22, 2021 | Sep. 22, 2021 | |||
SHARES/PAR VALUE | 500,000 | 500,000 | |||
COST BASIS | $ 500,000 | $ 500,000 | |||
VALUE | $ 372,880 | $ 500,000 | |||
Intraop Medical Corp 13 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Oct. 06, 2021 | Oct. 06, 2021 | |||
SHARES/PAR VALUE | 500,000 | 500,000 | |||
COST BASIS | $ 500,000 | $ 500,000 | |||
VALUE | $ 372,880 | $ 500,000 | |||
Intraop Medical Corp 14 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Oct. 22, 2021 | Oct. 22, 2021 | |||
SHARES/PAR VALUE | 1,000,000 | 1,000,000 | |||
COST BASIS | $ 1,000,000 | $ 1,000,000 | |||
VALUE | $ 745,760 | $ 1,000,000 | |||
Intraop Medical Corp 15 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Nov. 12, 2021 | Nov. 12, 2021 | |||
SHARES/PAR VALUE | 500,000 | 500,000 | |||
COST BASIS | $ 500,000 | $ 500,000 | |||
VALUE | $ 372,880 | $ 500,000 | |||
Intraop Medical Corp 16 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Nov. 29, 2021 | Nov. 29, 2021 | |||
SHARES/PAR VALUE | 500,000 | 500,000 | |||
COST BASIS | $ 500,000 | $ 500,000 | |||
VALUE | $ 372,880 | $ 500,000 | |||
Intraop Medical Corp 17 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Preferred Stock - Series C *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Feb. 28, 2022 | Jul. 12, 2013 | |||
SHARES/PAR VALUE | 200,000 | 26,856,187 | |||
COST BASIS | $ 200,000 | $ 26,299,938 | |||
VALUE | $ 149,152 | $ 670,062 | |||
Intraop Medical Corp 18 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Term Note Matures December 2021 Interest Rate 8% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Mar. 30, 2022 | Feb. 28, 2014 | |||
SHARES/PAR VALUE | 150,000 | 3,000,000 | |||
COST BASIS | $ 150,000 | $ 3,000,000 | |||
VALUE | $ 111,864 | $ 3,000,000 | |||
Intraop Medical Corp 19 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | [1],[2],[4] | Term Note Matures December 2021 Interest Rate 8% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Apr. 06, 2022 | Feb. 10, 2017 | |||
SHARES/PAR VALUE | 350,000 | 2,000,000 | |||
COST BASIS | $ 350,000 | $ 2,000,000 | |||
VALUE | $ 261,016 | 2,000,000 | |||
Intraop Medical Corp 20 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 15% (1)(2)(4) | |||
ACQUISITION DATE | Jun. 10, 2022 | ||||
SHARES/PAR VALUE | 700,000 | ||||
COST BASIS | $ 700,000 | ||||
VALUE | $ 522,032 | $ 27,081,191 | |||
Intraop Medical Corp 21 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[3],[4] | Preferred Stock - Series C *(1)(2)(4) | |||
ACQUISITION DATE | Jul. 12, 2013 | ||||
SHARES/PAR VALUE | 26,856,187 | ||||
COST BASIS | $ 26,299,938 | ||||
VALUE | $ 0 | ||||
Intraop Medical Corp 22 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[4] | Term Note Matures December 2022 Interest Rate 8% (1)(2)(4) | |||
ACQUISITION DATE | Feb. 28, 2014 | ||||
SHARES/PAR VALUE | 3,000,000 | ||||
COST BASIS | $ 3,000,000 | ||||
VALUE | $ 2,237,280 | ||||
Intraop Medical Corp 23 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[4] | Term Note Matures December 2022 Interest Rate 8% (1)(2)(4) | |||
ACQUISITION DATE | Feb. 10, 2017 | ||||
SHARES/PAR VALUE | 2,000,000 | ||||
COST BASIS | $ 2,000,000 | ||||
VALUE | 1,491,520 | ||||
Intraop Medical Corp 24 [Member] | |||||
Net Investment Income [Line Items] | |||||
VALUE | $ 20,740,428 | ||||
Kyma Inc [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures March 2023 Interest Rate 10% (1)(4) | [2],[4] | Convertible Note Matures March 2022 Interest Rate 10% (1)(4) | [6],[8] | |
ACQUISITION DATE | Mar. 11, 2019 | Mar. 11, 2019 | |||
SHARES/PAR VALUE | 100,000 | 100,000 | |||
COST BASIS | $ 100,000 | $ 100,000 | |||
VALUE | $ 100,000 | $ 100,000 | |||
Lyncean Technologies Inc [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Preferred Stock - Series B *(1)(4) | [2],[3],[4] | Preferred Stock - Series B *(1)(4) | [6],[7],[8] | |
ACQUISITION DATE | Jul. 03, 2018 | Jul. 03, 2018 | |||
SHARES/PAR VALUE | 869,792 | 869,792 | |||
COST BASIS | $ 1,000,000 | $ 1,000,000 | |||
VALUE | $ 0 | $ 280,160 | |||
Revasum Inc [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | CDIs *(2) | [1],[3] | CDIs *(2) | [5],[7] | |
SHARES/PAR VALUE | 39,774,889 | 46,834,340 | |||
COST BASIS | $ 9,268,219 | $ 13,512,263 | |||
VALUE | $ 3,053,041 | $ 21,466,824 | |||
ACQUISITION DATE | 11/14/16 - 11/30/18 | 11/14/16 - 11/30/18 | |||
Silicon Genesis Corp [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Preferred Stock - Series 1-E *(1)(2)(4) | [1],[2],[3],[4] | Preferred Stock - Series 1-E *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Apr. 18, 2011 | Apr. 18, 2011 | |||
SHARES/PAR VALUE | 5,704,480 | 5,704,480 | |||
COST BASIS | $ 2,372,403 | $ 2,372,403 | |||
VALUE | $ 326,296 | $ 453,506 | |||
Silicon Genesis Corp 1 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Preferred Stock - Series 1-C *(1)(2)(4) | [1],[2],[3],[4] | Preferred Stock - Series 1-C *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Apr. 18, 2011 | Apr. 18, 2011 | |||
SHARES/PAR VALUE | 82,914 | 82,914 | |||
COST BASIS | $ 109,518 | $ 109,518 | |||
VALUE | $ 1,020 | $ 1,990 | |||
Silicon Genesis Corp 2 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Preferred Stock - Series 1-D *(1)(2)(4) | [1],[2],[3],[4] | Preferred Stock - Series 1-D *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Apr. 18, 2011 | Apr. 18, 2011 | |||
SHARES/PAR VALUE | 850,830 | 850,830 | |||
COST BASIS | $ 431,901 | $ 431,901 | |||
VALUE | $ 2,638 | $ 5,275 | |||
Silicon Genesis Corp 3 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Common Stock *(1)(2)(4) | [1],[2],[3],[4] | Common Stock *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Apr. 18, 2011 | ||||
SHARES/PAR VALUE | 921,892 | 921,892 | |||
COST BASIS | $ 169,045 | $ 169,045 | |||
VALUE | $ 111 | $ 277 | |||
ACQUISITION DATE | 4/18/11 - 6/12/12 | ||||
Silicon Genesis Corp 4 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Common Stock Warrants *(1)(2)(4) | [1],[2],[3],[4] | Common Stock Warrants *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Apr. 18, 2011 | Apr. 18, 2011 | |||
SHARES/PAR VALUE | 37,982 | 37,982 | |||
COST BASIS | $ 6,678 | $ 6,678 | |||
VALUE | $ 1 | $ 3 | |||
Silicon Genesis Corp 5 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Preferred Stock - Series 1-F *(1)(2)(4) | [1],[2],[3],[4] | Preferred Stock - Series 1-F *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Apr. 18, 2011 | Apr. 18, 2011 | |||
SHARES/PAR VALUE | 912,453 | 912,453 | |||
COST BASIS | $ 456,389 | $ 456,389 | |||
VALUE | $ 71,993 | $ 100,187 | |||
Silicon Genesis Corp 6 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Preferred Stock - Series 1-G *(1)(2)(4) | [1],[2],[3],[4] | Preferred Stock - Series 1-G *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Mar. 10, 2016 | Mar. 10, 2016 | |||
SHARES/PAR VALUE | 48,370,793 | 48,370,793 | |||
COST BASIS | $ 3,880,592 | $ 3,880,592 | |||
VALUE | $ 312,475 | $ 439,207 | |||
Silicon Genesis Corp 7 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Preferred Stock - Series 1-H *(1)(2)(4) | [1],[2],[3],[4] | Preferred Stock - Series 1-H *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Mar. 10, 2016 | Mar. 10, 2016 | |||
SHARES/PAR VALUE | 837,942 | 837,942 | |||
COST BASIS | $ 936,895 | $ 936,895 | |||
VALUE | 36,115 | 50,277 | |||
Silicon Genesis Corp 8 [Member] | |||||
Net Investment Income [Line Items] | |||||
VALUE | $ 750,649 | $ 1,050,722 | |||
Uct Coatings Inc [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Common Stock *(1)(3)(4) | [2],[3],[4],[9] | Common Stock *(1)(3)(4) | [6],[7],[8],[10] | |
ACQUISITION DATE | Apr. 18, 2011 | Apr. 18, 2011 | |||
SHARES/PAR VALUE | 1,500,000 | 1,500,000 | |||
COST BASIS | $ 662,235 | $ 662,235 | |||
VALUE | $ 379,650 | $ 613,650 | |||
Wright Speed Inc [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Common Stock *(1)(2)(4) | [1],[2],[3],[4] | Common Stock *(1)(2)(4) | [5],[6],[7],[8] | |
SHARES/PAR VALUE | 69,102 | 69,102 | |||
COST BASIS | $ 7,460,851 | $ 7,460,851 | |||
VALUE | $ 567 | $ 1,126 | |||
ACQUISITION DATE | 4/11/13 - 5/6/19 | 4/11/13 - 5/6/19 | |||
Wright Speed Inc 1 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Jun. 07, 2019 | Jun. 07, 2019 | |||
SHARES/PAR VALUE | 4,929,015 | 4,929,015 | |||
COST BASIS | $ 4,929,015 | $ 4,929,015 | |||
VALUE | $ 2,267,347 | $ 4,929,015 | |||
Wright Speed Inc 2 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Aug. 12, 2020 | Aug. 12, 2020 | |||
SHARES/PAR VALUE | 750,000 | 750,000 | |||
COST BASIS | $ 750,000 | $ 750,000 | |||
VALUE | $ 345,000 | $ 750,000 | |||
Wright Speed Inc 3 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Sep. 10, 2020 | Sep. 10, 2020 | |||
SHARES/PAR VALUE | 900,000 | 900,000 | |||
COST BASIS | $ 900,000 | $ 900,000 | |||
VALUE | $ 414,000 | $ 900,000 | |||
Wright Speed Inc 4 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Oct. 13, 2020 | Oct. 13, 2020 | |||
SHARES/PAR VALUE | 1,050,000 | 1,050,000 | |||
COST BASIS | $ 1,050,000 | $ 1,050,000 | |||
VALUE | $ 483,000 | $ 1,050,000 | |||
Wright Speed Inc 5 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Nov. 11, 2020 | Nov. 11, 2020 | |||
SHARES/PAR VALUE | 400,000 | 400,000 | |||
COST BASIS | $ 400,000 | $ 400,000 | |||
VALUE | $ 184,000 | $ 400,000 | |||
Wright Speed Inc 6 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Nov. 24, 2020 | Nov. 24, 2020 | |||
SHARES/PAR VALUE | 375,000 | 375,000 | |||
COST BASIS | $ 375,000 | $ 375,000 | |||
VALUE | $ 172,500 | $ 375,000 | |||
Wright Speed Inc 7 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Dec. 11, 2020 | Dec. 11, 2020 | |||
SHARES/PAR VALUE | 400,000 | 400,000 | |||
COST BASIS | $ 400,000 | $ 400,000 | |||
VALUE | $ 184,000 | $ 400,000 | |||
Wright Speed Inc 8 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Dec. 23, 2020 | Dec. 23, 2020 | |||
SHARES/PAR VALUE | 2,000,000 | 2,000,000 | |||
COST BASIS | $ 2,000,000 | $ 2,000,000 | |||
VALUE | $ 920,000 | $ 2,000,000 | |||
Wright Speed Inc 9 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Feb. 23, 2021 | Feb. 23, 2021 | |||
SHARES/PAR VALUE | 1,400,000 | 1,400,000 | |||
COST BASIS | $ 1,400,000 | $ 1,400,000 | |||
VALUE | $ 644,000 | $ 1,400,000 | |||
Wright Speed Inc 10 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Apr. 12, 2021 | Apr. 12, 2021 | |||
SHARES/PAR VALUE | 1,200,000 | 1,200,000 | |||
COST BASIS | $ 1,200,000 | $ 1,200,000 | |||
VALUE | $ 552,000 | $ 1,200,000 | |||
Wright Speed Inc 11 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | May 18, 2021 | May 18, 2021 | |||
SHARES/PAR VALUE | 1,000,000 | 1,000,000 | |||
COST BASIS | $ 1,000,000 | $ 1,000,000 | |||
VALUE | $ 460,000 | $ 1,000,000 | |||
Wright Speed Inc 12 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Jun. 22, 2021 | Jun. 22, 2021 | |||
SHARES/PAR VALUE | 1,000,000 | 1,000,000 | |||
COST BASIS | $ 1,000,000 | $ 1,000,000 | |||
VALUE | $ 460,000 | $ 1,000,000 | |||
Wright Speed Inc 13 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Jul. 26, 2021 | Jul. 26, 2021 | |||
SHARES/PAR VALUE | 1,000,000 | 1,000,000 | |||
COST BASIS | $ 1,000,000 | ||||
VALUE | $ 460,000 | $ 1,000,000 | |||
Wright Speed Inc 14 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | |||
ACQUISITION DATE | Aug. 19, 2021 | ||||
SHARES/PAR VALUE | 1,000,000 | ||||
COST BASIS | $ 1,000,000 | $ 1,000,000 | |||
VALUE | $ 460,000 | ||||
Wright Speed Inc 15 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Sep. 22, 2021 | Aug. 19, 2021 | |||
SHARES/PAR VALUE | 300,000 | 1,000,000 | |||
COST BASIS | $ 300,000 | $ 1,000,000 | |||
VALUE | $ 138,000 | $ 1,000,000 | |||
Wright Speed Inc 16 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Oct. 05, 2021 | Sep. 22, 2021 | |||
SHARES/PAR VALUE | 700,000 | 300,000 | |||
COST BASIS | $ 700,000 | $ 300,000 | |||
VALUE | $ 322,000 | $ 300,000 | |||
Wright Speed Inc 17 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Oct. 20, 2021 | Oct. 05, 2021 | |||
SHARES/PAR VALUE | 1,000,000 | 700,000 | |||
COST BASIS | $ 1,000,000 | $ 700,000 | |||
VALUE | $ 460,000 | $ 700,000 | |||
Wright Speed Inc 18 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Nov. 23, 2021 | Oct. 20, 2021 | |||
SHARES/PAR VALUE | 1,000,000 | 1,000,000 | |||
COST BASIS | $ 1,000,000 | $ 1,000,000 | |||
VALUE | $ 460,000 | $ 1,000,000 | |||
Wright Speed Inc 19 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Dec. 28, 2021 | Nov. 23, 2021 | |||
SHARES/PAR VALUE | 1,000,000 | 1,000,000 | |||
COST BASIS | $ 1,000,000 | $ 1,000,000 | |||
VALUE | $ 460,000 | $ 1,000,000 | |||
Wright Speed Inc 20 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [5],[6],[8] | |
ACQUISITION DATE | Feb. 23, 2022 | Dec. 28, 2021 | |||
SHARES/PAR VALUE | 200,000 | 1,000,000 | |||
COST BASIS | $ 200,000 | $ 1,000,000 | |||
VALUE | $ 92,000 | $ 1,000,000 | |||
Wright Speed Inc 21 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Preferred Stock - Series AA *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Mar. 11, 2022 | ||||
SHARES/PAR VALUE | 185,000 | 60,733,693 | |||
COST BASIS | $ 185,000 | $ 17,355,887 | |||
VALUE | $ 85,100 | $ 1,777,068 | |||
ACQUISITION DATE | 6/7/2019 - 7/20/2020 | ||||
Wright Speed Inc 22 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | [1],[2],[4] | Preferred Stock Warrants - Series AA *(1)(2)(4) | [5],[6],[7],[8] | |
ACQUISITION DATE | Apr. 14, 2022 | Jun. 07, 2019 | |||
SHARES/PAR VALUE | 65,000 | 609,756 | |||
COST BASIS | $ 65,000 | $ 0 | |||
VALUE | $ 29,900 | $ 7,500 | |||
Wright Speed Inc 23 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | |||
ACQUISITION DATE | May 10, 2022 | ||||
SHARES/PAR VALUE | 250,000 | ||||
COST BASIS | $ 250,000 | ||||
VALUE | $ 115,000 | ||||
Wright Speed Inc 24 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | |||
ACQUISITION DATE | May 26, 2022 | ||||
SHARES/PAR VALUE | 250,000 | ||||
COST BASIS | $ 250,000 | ||||
VALUE | $ 115,000 | ||||
Wright Speed Inc 25 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | |||
ACQUISITION DATE | Jun. 10, 2022 | ||||
SHARES/PAR VALUE | 250,000 | ||||
COST BASIS | $ 250,000 | ||||
VALUE | $ 115,000 | ||||
Wright Speed Inc 26 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | |||
ACQUISITION DATE | Jun. 28, 2022 | ||||
SHARES/PAR VALUE | 250,000 | ||||
COST BASIS | $ 250,000 | ||||
VALUE | $ 115,000 | ||||
Wright Speed Inc 27 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | |||
ACQUISITION DATE | Jul. 13, 2022 | ||||
SHARES/PAR VALUE | 250,000 | ||||
COST BASIS | $ 250,000 | ||||
VALUE | $ 115,000 | ||||
Wright Speed Inc 28 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | |||
ACQUISITION DATE | Jul. 28, 2022 | ||||
SHARES/PAR VALUE | 250,000 | ||||
COST BASIS | $ 250,000 | ||||
VALUE | $ 115,000 | ||||
Wright Speed Inc 29 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[4] | Convertible Note Matures December 2022 Interest Rate 12% (1)(2)(4) | |||
ACQUISITION DATE | Aug. 12, 2022 | ||||
SHARES/PAR VALUE | 250,000 | ||||
COST BASIS | $ 250,000 | ||||
VALUE | $ 115,000 | ||||
Wright Speed Inc 30 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[3],[4] | Preferred Stock - Series AA *(1)(2)(4) | |||
SHARES/PAR VALUE | 60,733,693 | ||||
COST BASIS | $ 17,355,887 | ||||
VALUE | $ 1,074,986 | ||||
ACQUISITION DATE | 6/7/19 - 7/20/20 | ||||
Wright Speed Inc 31 [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [1],[2],[3],[4] | Preferred Stock Warrants - Series AA *(1)(2)(4) | |||
ACQUISITION DATE | Jun. 07, 2019 | ||||
SHARES/PAR VALUE | 609,756 | ||||
COST BASIS | $ 0 | ||||
VALUE | 3,414 | ||||
Wright Speed Inc 32 [Member] | |||||
Net Investment Income [Line Items] | |||||
VALUE | $ 11,936,814 | ||||
Investment Company [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | Fidelity Investments Money Market Treasury Portfolio - Class I (5) | [11] | Fidelity Investments Money Market Treasury Portfolio - Class I (5) | [12] | |
SHARES/PAR VALUE | 1,142,833 | 629,653 | |||
COST BASIS | $ 1,142,833 | $ 629,653 | |||
VALUE | $ 1,142,833 | $ 629,653 | |||
ACQUISITION DATE | Various | Various | |||
Eqx Capital Inc 2 [Member] | |||||
Net Investment Income [Line Items] | |||||
VALUE | $ 1,929,910 | ||||
Pivotal Systems Corp [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [5],[7] | CDIs *(2) | |||
SHARES/PAR VALUE | 14,589,506 | ||||
COST BASIS | $ 9,873 | ||||
VALUE | $ 9,287,771 | ||||
ACQUISITION DATE | 11/28/12 - 9/2/16 | ||||
Svxr Inc [Member] | |||||
Net Investment Income [Line Items] | |||||
TYPE OF INVESTMENT | [6],[7],[8],[10] | Preferred Stock - Series A *(1)(3)(4) | |||
SHARES/PAR VALUE | 8,219,454 | ||||
COST BASIS | $ 4,082,192 | ||||
VALUE | $ 0 | ||||
ACQUISITION DATE | 1/11/17 - 8/29/18 | ||||
[1]Controlled investments.[2]Fair Value Level 3 security.[3]Non-income producing security.[4]Restricted security. Fair Value is determined by or under the direction of the Company’s Board of Directors (See note 3). At September 30, 2022, we held $42,408,025 (or 110.3% of net assets) in restricted securities (see Note 2).[5]Controlled investments.[6]Fair Value Level 3 security.[7]Non-income producing security.[8]Restricted security. Fair Value is determined by or under the direction of the Company’s Board of Directors (See note 3). At December 31, 2021, we held $59,744,294 (or 63.1% of net assets) in restricted securities (see Note 2).[9]Affiliated issuer.[10]Affiliated issuer.[11]The Fidelity Investments Money Market Portfolio invests primarily in U.S. Treasury securities.[12]The Fidelity Investments Money Market Portfolio invests primarily in U.S. Treasury securities. |
THE COMPANY
THE COMPANY | 9 Months Ended |
Sep. 30, 2022 | |
Investment Company [Abstract] | |
THE COMPANY | NOTE 1. THE COMPANY Firsthand Technology Value Fund, Inc. (the “Company,” the “Fund,” “us,” “our,” and “we”), is a Maryland corporation and an externally managed, non-diversified, closed-end management investment company that has elected to be treated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). The Company acquired its initial portfolio of securities through the reorganization of Firsthand Technology Value Fund, a series of Firsthand Funds, into the Company. The reorganization was completed on April 15, 2011. The Company commenced operations on April 18th, 2011. Under normal circumstances, the Company will invest at least 80% of its assets for investment purposes in technology companies, which are considered to be those companies that derive at least 50% of their revenues from products and/ or services within the information technology sector or the “cleantech” sector. Information technology companies include, but are not limited to, those focused on computer hardware, software, telecommunications, networking, Internet, and consumer electronics. While there is no standard definition of cleantech, it is generally regarded as including goods and services designed to harness renewable energy and materials, eliminate emissions and waste, and reduce the use of natural resources. In addition, under normal circumstances we will invest at least 70% of our assets in privately held companies and in public companies with market capitalizations less than $250 million. Our portfolio is primarily composed of equity and equity derivative securities of technology and cleantech companies (as defined above). These investments generally range between $1 million and $10 million each, although the investment size will vary proportionately with the size of the Company’s capital base. The Company’s shares are listed on the NASDAQ Global Market under the symbol “SVVC.” Firsthand Capital Management, Inc., which was previously known as SiVest Group, Inc. (“FCM” or the “Advisor”), serves as the investment adviser to the Company. The Company is an investment company and follows accounting and reporting guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 946. CONSOLIDATION OF SUBSIDIARIES. During the fiscal years ended December 31, 2016 and 2017, with the approval of its Board of Directors, the Company organized three separate fully owned and controlled subsidiaries (as defined by the 1940 Act). Each subsidiary was a Cayman Islands corporation and the financial statements of each subsidiary were reported on a consolidated basis with the Company. Each subsidiary was formed for the purpose of holding one or more investments made by the Company, and was treated as a controlled foreign corporation under the Internal Revenue Code not separately subject to U.S. federal income tax. FVI was treated as the sole U.S. shareholder of each subsidiary. The Board of Directors of the Company approved the liquidation of those three Cayman subsidiaries on November 2, 2018. That liquidation was completed on December 27, 2018. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES The following is a summary of significant accounting policies followed in the preparation of the Company’s financial statements included in this report: BASIS OF PRESENTATION Financial Services—Investment Companies Under the 1940 Act, ASC 946, and the regulations pursuant to Article 6 of Regulation S-X, we are precluded from consolidating any entity other than another investment company or an operating company which provides substantially all of its services to benefit us. Consequentially, as of December 31, 2018, the Company consolidated some special purpose entities. These special purpose entities only hold investments of the Company and have no other significant asset and liabilities. All significant intercompany transactions and balances have been eliminated in consolidation. USE OF ESTIMATES PORTFOLIO INVESTMENT VALUATIONS 40.0 CASH AND CASH EQUIVALENTS RESTRICTED SECURITIES 42,408,025 59,744,294 INCOME RECOGNITION 10.4 16.3 SHARE VALUATION REALIZED GAIN OR LOSS AND UNREALIZED APPRECIATION OR DEPRECIATION OF PORTFOLIO INVESTMENTS INCOME TAXES FOREIGN CURRENCY TRANSLATION SECURITIES TRANSACTIONS i.e. CONCENTRATION OF CREDIT RISK OPTIONS Premiums received from writing options that expire unexercised are treated by the Company on the expiration date as realized gains from investments. The difference between the premium and the amount paid on effecting a closing purchase transaction, including brokerage commissions, is also treated as a realized gain, or, if the premium is less than the amount paid for the closing purchase transaction, as a realized loss. If a call option is exercised, the premium is added to the proceeds from the sale of the underlying security or currency in determining whether the Company has realized a gain or loss. The Company as writer of an option bears the market risk of an unfavorable change in the price of the security underlying the written option. The average quarterly volume of the Company’s derivatives during the nine months ended September 30, 2022 is as follows: Schedule of derivatives PURCHASED OPTIONS WARRANTS WRITTEN OPTIONS Firsthand Technology Value Fund, Inc. — 843,845 — |
BUSINESS RISKS AND UNCERTAINTIE
BUSINESS RISKS AND UNCERTAINTIES | 9 Months Ended |
Sep. 30, 2022 | |
Business Risks And Uncertainties | |
BUSINESS RISKS AND UNCERTAINTIES | NOTE 3. BUSINESS RISKS AND UNCERTAINTIES We invest a substantial portion of our assets in privately-held companies, the securities of which are inherently illiquid. We also seek to invest in small publicly-traded companies that we believe have exceptional growth potential and to make opportunistic investments in publicly-traded companies, both large and small. In the case of investments in small publicly-traded companies, although these companies are publicly traded, their stock may not trade at high volumes, and prices can be volatile, which may restrict our ability to sell our positions. We may also be subject to contractual restrictions or securities law limits on our ability to sell portfolio holdings because of, for example, our affiliation with a portfolio company or the relative size of our holding in a company. These privately held and publicly traded businesses tend to lack management depth, have limited or no history of operations and typically have not attained profitability. Because of the speculative nature of our investments and the lack of public markets for privately held investments, there is greater risk of loss than is the case with traditional investment securities. We do not choose investments based on a strategy of diversification. We also do not rebalance the portfolio should one of our portfolio companies increase in value substantially relative to the rest of the portfolio. Therefore, the value of our portfolio may be more vulnerable to events affecting a single sector, industry or portfolio company and, therefore, may be subject to greater volatility than a company that follows a diversification strategy. Because there is typically no public or readily-ascertainable market for our interests in the small privately-held companies in which we invest, the valuation of those securities is determined in good faith by the Valuation Committee, comprised of all members of the Board who are not “interested persons” of the Company, as such term is defined in Section 2(a)(19) of the 1940 Act, in accordance with our Valuation Procedures and is subject to significant estimates and judgments. The determined value of the securities in our portfolio may differ significantly from the values that would be placed on these securities if a ready market for the securities existed. Any changes in valuation are recorded in our Statement of Operations as “Net increase (decrease) in unrealized appreciation on investments.” Changes in valuation of any of our investments in privately-held companies from one period to another may be volatile. The Board has engaged an independent valuation firm to provide it with valuation assistance with respect to certain of our portfolio investments. The Company intends to continue to engage an independent valuation firm to provide us with assistance regarding our determination of the fair value of select portfolio investments each quarter unless directed by the Board to cancel such valuation services. The scope of the services rendered by an independent valuation firm is at the discretion of the Board. The Board is ultimately and solely responsible for determining the fair value of the Company’s investments in good faith. With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value, the Board has approved a multi-step valuation process to be followed each quarter, as described below: (1) each quarter the valuation process begins with each portfolio company or investment being initially valued by the Advisor’s Valuation Committee or the independent valuation firm; (2) the Valuation Committee of the Board on a quarterly basis reviews the preliminary valuation of the Advisor’s Valuation Committee and that of the independent valuation firms and makes the fair value determination, in good faith, based on the valuation recommendations of the Advisor’s Valuation Committee and the independent valuation firms; and (3) at each quarterly Board meeting, the Board considers the valuations recommended by the Advisor’s Valuation Committee and the independent valuation firms that were previously submitted to the Valuation Committee of the Board and ratifies the fair value determinations made by the Valuation Committee of the Board. |
INVESTMENT MANAGEMENT FEE
INVESTMENT MANAGEMENT FEE | 9 Months Ended |
Sep. 30, 2022 | |
Investment Management Fee | |
INVESTMENT MANAGEMENT FEE | NOTE 4. INVESTMENT MANAGEMENT FEE The Company has entered into an investment management agreement (the “Investment Management Agreement”) with FCM pursuant to which the Company will pay FCM a fee for providing investment management services consisting of two components—a base management fee and an incentive fee. The base management fee will be calculated at an annual rate of 2.00 The incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Management Agreement, as of the termination date), commencing on April 15, 2011, and equals 20% of the Company’s realized capital gains, if any, on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid incentive fees, provided that the incentive fee determined as of December 31, 2021, will be calculated for a period of shorter than twelve calendar months to take into account any realized gains computed net of all realized capital losses and unrealized capital depreciation from inception. For the three months ended September 30, 2022, there were no incentive fee adjustments. For the three months ended September 30, 2021, there were no incentive fee adjustments. |
DEBT
DEBT | 9 Months Ended |
Sep. 30, 2022 | |
Debt Disclosure [Abstract] | |
DEBT | NOTE 5. DEBT The Company currently has no plan to use leverage and does not have any significant outstanding debt obligations (other than normal operating expense accruals). |
FAIR VALUE
FAIR VALUE | 9 Months Ended |
Sep. 30, 2022 | |
Fair Value Disclosures [Abstract] | |
FAIR VALUE | NOTE 6. FAIR VALUE Securities traded on stock exchanges, or quoted by NASDAQ, are valued according to the NASDAQ Stock Market, Inc. (“NASDAQ”) official closing price, if applicable, or at their last reported sale price as of the close of trading on the New York Stock Exchange (“NYSE”) (normally 4:00 P.M. Eastern Time). If a security is not traded that day, the security will be valued at its most recent bid price. Securities traded in the over-the-counter market, but not quoted by NASDAQ, are valued at the last sale price (or, if the last sale price is not readily available, at the most recent closing bid price as quoted by brokers that make markets in the securities) at the close of trading on the NYSE. Securities traded both in the over-the-counter market and on a stock exchange are valued according to the broadest and most representative market. Securities and other assets that do not have market quotations readily available are valued at their fair value as determined by FCM, as the Board’s valuation designee under SEC rule 2a-5. Those valuations are determined in accordance with the Valuation Procedures used by FCM, subject to oversight by the Board. In pricing illiquid, privately placed securities, FCM, as the valuation designee, is responsible for (1) determining overall valuation guidelines and (2) ensuring that the investments of the Company are valued within the prescribed guidelines. FCM and the Board receive information and recommendations from an independent valuation firm. The values assigned to these investments are based on available information and do not necessarily represent amounts that might ultimately be realized when that investment is sold, as such amounts depend on future circumstances and cannot reasonably be determined until the individual investments are actually liquidated or become readily marketable. APPROACHES TO DETERMINING FAIR VALUE. The main approaches to measuring fair value utilized are the market approach, the income approach, and the asset-based approach. The choice of which approach to use in a particular situation depends on the specific facts and circumstances associated with the company, as well as the purpose for which the valuation analysis is being conducted. Firsthand and the independent valuation firm rely primarily on the market approach. We also considered the income and asset-based approaches in our analysis because certain of the portfolio companies do not have substantial operating earnings relative to the value of their underlying assets. - Market Approach (M): The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. For example, the market approach often uses market multiples derived from a set of comparables. Multiples might lie in ranges with a different multiple for each comparable. The selection of where within the range each appropriate multiple falls requires the use of judgment in considering factors specific to the measurement (qualitative and quantitative). - Income Approach (I): The income approach uses valuation techniques to convert future amounts (for example, cash flows or earnings) to a single present value amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. Those valuation techniques include present value techniques; option-pricing models, such as the Black-Scholes-Merton formula (a closed-form model) and a binomial model (a lattice model), which incorporate present value techniques; and the multi-period excess earnings method, which is used to measure the fair value of certain assets. - Asset-Based Approach (A): The asset-based approach examines the value of a company’s assets net of its liabilities to derive a value for the equity holders. FAIR VALUE MEASUREMENT. The guidance establishes three levels of the fair value hierarchy as follows: Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access at the date of measurement. Level 2 - Observable inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These inputs may include quoted prices for the identical instrument in an inactive market, prices for similar instruments in an active or inactive market, interest rates, prepayment speeds, credit risks, yield curves, default rates, and similar data. Level 3 - Unobservable inputs for the asset or liability, to the extent relevant observable inputs are not available, representing the Company’s own assumptions about the assumptions a market participant would use in valuing the asset or liability based on the best information available. The availability of observable inputs can vary from security to security and is affected by a wide variety of factors, including, for example, the type of security, whether the security is new and not yet established in the marketplace, the liquidity of markets, and other characteristics particular to the security. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement falls in its entirety, is determined based on the lowest level input that is significant to the fair value measurement in its entirety. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The following is a summary of the inputs used to value the Company’s net assets as of September 30, 2022: Schedule of fair value of net asset ASSETS LEVEL 1 LEVEL 2 OTHER LEVEL 3 SIGNIFICANT Common Stocks Advanced Materials $ — $ — $ 379,650 Automotive — — 567 Equipment Leasing — — 16,220 Intellectual Property — — 111 Semiconductor Equipment 3,053,041 — — Total Common Stocks 3,053,041 — 396,548 Preferred Stocks Aerospace — — 597,131 Automotive — — 1,074,986 Equipment Leasing — — 1,183,820 Intellectual Property — — 750,537 Total Preferred Stocks — — 3,606,474 Asset Derivatives * Equity Contracts — — 1,471,728 Total Asset Derivatives — — 1,471,728 Convertible Notes Advanced Materials — — 100,000 Aerospace — — 5,235,000 Automotive — — 10,857,847 Medical Devices — — 20,740,428 Total Convertible Notes — — 36,933,275 Mutual Funds 1,142,833 — — Total $ 4,195,874 $ — $ 42,408,025 * Asset derivatives include warrants. At the end of each calendar quarter, management evaluates the Level 2 and Level 3 assets and liabilities for changes in liquidity, including but not limited to: whether a broker is willing to execute at the quoted price, the depth and consistency of prices from third party services, and the existence of contemporaneous, observable trades in the market. Additionally, management evaluates the Level 1 and Level 2 assets and liabilities on a quarterly basis for changes in listings or delistings on national exchanges. Following is a reconciliation of Level 3 assets (at either the beginning or the ending of the period) for which significant unobservable inputs were used to determine fair value. Schedule of unobservable inputs of fair value INVESTMENTS AT FAIR BALANCE NET NET SALES/ NET REALIZED NET UNREALIZED (1) TRANSFERS BALANCE Common Stocks Advanced Materials $ 613,650 $ — $ — $ — $ (234,000 ) $ — $ 379,650 Automotive 1,126 — — — (559 ) — 567 Equipment Leasing 31,490 — — — (15,270 ) — 16,220 Intellectual Property 277 — — — (166 ) — 111 Total Common Stocks 646,543 — — — (249,995 ) — 396,548 Preferred Stocks Aerospace 324,245 — — — 272,886 — 597,131 Automotive 1,777,068 — — — (702,082 ) — 1,074,986 Equipment Leasing 1,898,420 — (100,000 ) — (614,600 ) — 1,183,820 Intellectual Property 1,050,442 — — — (299,905 ) — 750,537 Medical Devices 670,062 — — — (670,062 ) — — Semiconductor Equipment 280,160 — — (4,082,192 ) 3,802,032 — — Total Preferred Stocks 6,000,397 — (100,000 ) (4,082,192 ) 1,788,269 — 3,606,474 Asset Derivatives Equity Contracts 802,210 — — — 669,518 — 1,471,728 Total Asset Derivatives 802,210 — — — 669,518 — 1,471,728 Convertible Notes Advanced Materials 100,000 — — — — — 100,000 Aerospace 4,380,000 855,000 — — — — 5,235,000 Automotive 21,404,015 2,200,000 — — (12,746,168 ) — 10,857,847 Medical Devices 26,411,129 1,400,000 — — (7,070,701 ) — 20,740,428 Total Convertible Notes 52,295,144 4,455,000 — — (19,816,869 ) — 36,933,275 Total $ 59,744,294 $ 4,455,000 $ (100,000 ) $ (4,082,192 ) $ (17,609,077 ) $ — $ 42,408,025 (1) The net change in unrealized appreciation (depreciation) from Level 3 instruments held as of September 30, 2022 was $(21,691,268). The table below represents quantitative disclosure about significant unobservable inputs for Level 3 fair value measurements at September 30, 2022: Schedule of unobservable inputs fair value measurements FAIR VALUATION TECHNIQUES UNOBSERVABLE INPUTS RANGE Direct venture capital investments: Advanced Materials $ 0.5 Market Comparable Companies Option Pricing Model EBITDA Multiple Revenue Multiple Years to Maturity Volatility Risk-Free Rate Discount for Lack of Marketability 4.9x - 6.4x (5.7x) 0.6x – 0.6x (0.6x) 5 years (5 years) 50.0% (50.0%) 4.06% (4.06%) 22.7% (22.7%) Direct venture capital investments: Aerospace $ 7.3 Market Comparable Companies Option Pricing Model EBITDA Multiple Years to Maturity Volatility Risk-Free Rate 7.0x – 10.2x (7.9x) 5 years (5 years) 60.0% (60.0%) 4.06% (4.06%) Direct venture capital investments: Automotive $ 11.9 Prior Transaction Analysis Option Pricing Model Probability-Weighted Expected Return Method Years to Maturity Volatility Risk-Free Rate Discount for Lack of Marketability Going Concern Probability 5 years (5 years) 50.0% (50.0%) 4.06% (4.06%) 0.0% - 22.7% (0.0%) 10% (10%) Direct venture capital investments: Equipment Leasing $ 1.2 Discounted Cash Flow Option Pricing Model Weighted Average Cost of Capital Years to Maturity Volatility Risk-Free Rate 20.0% (20.0%) 5 years (5 years) 50.0% (50.0%) 4.06% (4.06%) Direct venture capital investments: Intellectual Property $ 0.8 Discounted Cash Flow Option Pricing Model Weighted Average Cost of Capital Years to Maturity Volatility Risk-Free Rate Discount for Lack of Marketability 12.5% (12.5%) 5 years (5 years) 55.0% (55.0%) 4.06% (4.06%) 0.0% - 24.3% (0.0%) Direct venture capital investments: Medical Devices $ 20.7 Market Comparable Companies Revenue Multiple 1.9x – 2.2x (2.1x) |
FEDERAL INCOME TAXES
FEDERAL INCOME TAXES | 9 Months Ended |
Sep. 30, 2022 | |
Income Tax Disclosure [Abstract] | |
FEDERAL INCOME TAXES | NOTE 7. FEDERAL INCOME TAXES Beginning in 2018, we were no longer able to qualify as a RIC under Subchapter M of the Code. The increase in value that resulted from the initial public offerings (IPOs) of Pivotal Systems and Revasum meant that we were no longer able to satisfy the diversification requirements for qualification as a RIC. As a result of this change, we were taxed as a corporation for our fiscal year ended December 31, 2018, and will continue to be taxed in that manner for future fiscal years, paying federal and applicable state corporate taxes on our taxable income, unless and until we are able to once again qualify as a RIC, based on changes in the composition of our portfolio. Consequently, at the close of each fiscal quarter beginning with the quarter ended June 30, 2018, we will record a deferred tax liability for any net realized gains and net ordinary income for the year-to-date period plus net unrealized gains as of the end of the quarter. The reorganization described in Note 1 (the formation of FVI as a fully owned subsidiary for investment activities) was structured to avoid any adverse tax consequences for the Company and its shareholders. For the fiscal years which the Company operates as a RIC, we believe Company’s engaging in investment activities through FVI did not, in our view, jeopardize the Company’s ability to continue to qualify as a RIC under the Code at that time when the Company was eligible to be treated as a RIC. The following information is based upon the U.S. federal income tax cost of portfolio investments as of September 30, 2022. Schedule of federal income tax cost of portfolio investments FEDERAL INCOME Gross unrealized appreciation $ 1,471,727 Gross unrealized depreciation (96,628,458 ) Net unrealized (depreciation) $ (95,156,731 ) Federal income tax cost, Investments $ 141,760,630 The Company did not qualify as a regulated investment company pursuant to Subchapter M of the Internal Revenue Code, therefore it is taxed as a corporation. As a corporation, the Company is obligated to pay federal and state income tax on taxable income. The Company’s net deferred tax asset balance has a full valuation allowance based on management’s estimate of future realization of such assets. The Company is currently using an estimated tax rate of 21 6.98 The Company’s income tax provision consists of the following as of December 31, 2021 Schedule of income tax provision Deferred tax (expense)/benefit Federal $ — State — Total deferred tax (expense)/benefit $ — Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Such temporary differences are principally: (i) taxes on unrealized gains/(losses), which are attributable to the temporary difference between fair market value and tax basis, (ii) the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting and income tax purposes, and (iii) the net tax benefit of accumulated net operating losses and capital loss carryforwards. Deferred tax assets and liabilities are measured using effective tax rates expected to apply to taxable income in the years such temporary differences are realized or otherwise settled. Components of the Company’s deferred tax assets and liabilities as of December 31, 2021 are as follows: Schedule of deferred tax assets and liabilities AMOUNT Deferred tax assets: Net operating loss carryforward $ 261,739 Capital loss carryforward 6,084,731 Net unrealized losses (gains) on investment securities 15,137,185 Total deferred tax assets 21,483,655 Valuation allowance (21,483,655 ) Net $ — For the year ended December 31, 2021, the Company had an effective tax rate of 0 21 27.98 The effective tax rate and statutory federal income tax rate for the three- and nine-month periods ended September 30, 2022 and 2021 were as follows: Schedule of effective tax rate and statutory federal income tax rate THREE MONTHS ENDED THREE MONTHS ENDED NINE MONTHS ENDED NINE MONTHS ENDED Effective tax rate 0% 0% 0% 0% Statutory federal income tax rate 21% 21% 21% 21% The variance in the effective tax rate and statutory federal income tax rate for the three- and nine-month periods ending September 30, 2022, is the result of changes to the deferred tax assets and related valuation allowance account. At September 30, 2022 the Company has established a full valuation allowance on its net deferred tax assets. To the extent the Company has a deferred tax asset or if a portion of the deferred tax liability is offset by a tax asset resulting from net operating losses, consideration is given to whether or not a valuation allowance is required against the deferred tax asset amount. A valuation allowance is required if, based on the evaluation criterion provided by Accounting Standard Codification (“ASC”) 740, Income Taxes (ASC 740), it is more-likely-than-not that some portion or all of the deferred tax asset will not be realized. Among the factors considered in assessing the Company’s valuation allowance are: the nature, frequency and severity of current and cumulative losses, forecasts of future profitability, the duration of the statutory carryforward periods, and the associated risks that operating and capital loss carryforwards may expire unused. Based on the Company’s assessment, it has determined that in the future it is more likely than not that the Company will not generate the necessary appropriate character of income within the carryforward periods to realize its deferred tax assets, and as such, has placed a full allowance on the deferred tax assets. From time to time, and as new information becomes available, the Company will modify its forecasts, estimates or assumptions regarding its deferred tax liability or asset. Modifications of the Company’s estimates or assumptions regarding its deferred tax liability and/or asset balances and any applicable valuation allowance, changes in generally accepted accounting principles or related guidance or interpretations thereof, limitations imposed on net operating losses (if any), and changes in applicable tax law could result in increases or decreases in the Company’s NAV, which could be material. Such changes could have a material impact on the Company’s NAV and results of operations with respect to the Company’s shareholders in the period it is recorded, even though the shareholders at such time might not have held shares in the Company at the time the deferred tax asset or liability had been established. The Company’s policy is to classify interest and penalties associated with underpayment of federal and state income taxes, if any, as income tax expense on its Statement of Operations. As of December 31, 2021, the Company did not have any interest or penalties associated with the underpayment of any income taxes. The Company files income tax returns in the U.S. federal jurisdiction and California. The Company has reviewed all major jurisdictions and concluded that there is no significant impact on the Company’s net assets and no tax liability resulting from unrecognized tax benefits relating to uncertain tax positions expected to be taken on its tax returns. Furthermore, management of the Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next 12 months. As of December 31, 2021, the Company had net operating loss carryforwards for federal and state of income tax purposes of $ 935,449 As of December 31, 2021, the Company had net capital loss carryforwards for federal and state income tax purposes, which may be carried forward for 5 Schedule of net capital loss carryforwards EXPIRATION DATE AMOUNT 12/31/24 $ 14,230,073 12/31/25 7,516,642 Total $ 21,746,715 |
INVESTMENT TRANSACTIONS
INVESTMENT TRANSACTIONS | 9 Months Ended |
Sep. 30, 2022 | |
Investments, All Other Investments [Abstract] | |
INVESTMENT TRANSACTIONS | NOTE 8. INVESTMENT TRANSACTIONS Investment transactions (excluding short-term investments) were as follows for the quarter ended September 30, 2022. Schedule of investment transactions PURCHASES AND SALES Purchases of investment securities $ 2,734 Proceeds from sales and maturities of investment securities $ 5,307,261 |
SHARE BUYBACKS
SHARE BUYBACKS | 9 Months Ended |
Sep. 30, 2022 | |
Equity [Abstract] | |
SHARE BUYBACKS | NOTE 9. SHARE BUYBACKS SHARE BUYBACKS. 272,008 2 On November 10, 2017, the Board of Directors of the Fund approved a discretionary share purchase plan (the “Plan”). Pursuant to the Plan, the Fund was authorized to purchase in the open market up to $ 2 of the Exchange Act. The intent of the Plan was to increase NAV per share and thereby enhance shareholder value. As of December 31, 2017, the Fund had repurchased and retired 128,551 1.1 7,302,146 On August 31, 2018, the Fund announced a plan to repurchase up to $ 2 123,376 16.21 2.0 7,178,770 TENDER OFFERS. 20 23.2702 Of the 5,044,728 shares properly tendered, the Fund purchased 859,468 shares of common stock pursuant to the tender offer. On December 16, 2019, the Fund announced the commencement of a “modified Dutch auction” tender offer to purchase up to $ 2 February 14, 2020 285,714 7.00 6,893,056 |
INVESTMENTS IN AFFILIATES AND C
INVESTMENTS IN AFFILIATES AND CONTROLLED INVESTMENTS | 9 Months Ended |
Sep. 30, 2022 | |
Investments in and Advances to Affiliates [Abstract] | |
INVESTMENTS IN AFFILIATES AND CONTROLLED INVESTMENTS | NOTE 10. INVESTMENTS IN AFFILIATES AND CONTROLLED INVESTMENTS Under the 1940 Act, the Company is required to identify investments where it owns greater than 5% (but less than 25%) of the portfolio company’s outstanding voting shares as an affiliate of the Company. Also, under the 1940 Act, the Company is required to identify investments where it owns greater than 25% of the portfolio company’s outstanding voting shares as a controlled investment of the Company. A summary of the Company’s investments in affiliates and controlled investments for the period from December 31, 2021, through September 30, 2022, is noted below: Schedule of investments in affiliates and controlled investments AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD EQX Capital, Inc. Common Stock * $ 31,490 $ — $ — $ — $ — $ (15,270 ) $ 16,220 100,000 EQX Capital, Inc. Series A Preferred Stock * 1,898,420 — — (100,000 ) — (614,600 ) 1,183,820 2,200,000 Hera Systems, Inc. Convertible Note * 40,000 — 3,533 — — — 40,000 40,000 Hera Systems, Inc. Convertible Note * — 100,000 2,222 — — — 100,000 100,000 Hera Systems, Inc. Convertible Note * 200,000 — 15,696 — — — 200,000 200,000 Hera Systems, Inc. Convertible Note * — 55,000 2,200 — — — 55,000 55,000 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Hera Systems, Inc. Convertible Note * $ 150,000 $ — $ 12,334 $ — $ — $ — $ 150,000 150,000 Hera Systems, Inc. Convertible Note * 150,000 — 12,626 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * 150,000 — 11,527 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * — 70,000 312 (70,000 ) — — — — Hera Systems, Inc. Convertible Note * 150,000 — 11,375 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * 150,000 — 11,375 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * 150,000 — 11,375 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * 150,000 — 11,658 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * — 90,000 2,375 — — — 90,000 90,000 Hera Systems, Inc. Convertible Note * 200,000 — 17,306 — — — 200,000 200,000 Hera Systems, Inc. Convertible Note * — 75,000 2,354 — — — 75,000 75,000 Hera Systems, Inc. Convertible Note * — 75,000 3,292 — — — 75,000 75,000 Hera Systems, Inc. Convertible Note * — 75,000 2,667 — — — 75,000 75,000 Hera Systems, Inc. Convertible Note * — 150,000 9,708 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * 500,000 — 52,986 — — — 500,000 500,000 Hera Systems, Inc. Convertible Note * 50,000 — 4,141 — — — 50,000 50,000 Hera Systems, Inc. Convertible Note * 150,000 — 12,038 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * 150,000 — 12,178 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * — 70,000 3,325 — — — 70,000 70,000 Hera Systems, Inc. Convertible Note * 250,000 — 20,881 — — — 250,000 250,000 Hera Systems, Inc. Convertible Note * 500,000 — 55,470 — — — 500,000 500,000 Hera Systems, Inc. Convertible Note * 250,000 — 20,880 — — — 250,000 250,000 41 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Hera Systems, Inc. Convertible Note * $ 250,000 $ — $ 22,369 $ — $ — $ — $ 250,000 250,000 Hera Systems, Inc. Convertible Note * 220,000 — 18,757 — — — 220,000 220,000 Hera Systems, Inc. Convertible Note * 20,000 — 1,748 — — — 20,000 20,000 Hera Systems, Inc. Convertible Note * 150,000 — 11,375 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * — 90,000 4,650 — — — 90,000 90,000 Hera Systems, Inc. Convertible Note * — 75,000 4,250 — — — 75,000 75,000 Hera Systems, Inc. Convertible Note * 250,000 — 20,881 — — — 250,000 250,000 Hera Systems, Inc. Convertible Note * 150,000 — 11,924 — — — 150,000 150,000 Hera Systems, Inc. Series C Preferred * 86,390 — — — — 73,140 159,530 2,650,000 Hera Systems, Inc. Series A Preferred * 8,377 — — — — 5,464 13,841 3,642,324 Hera Systems, Inc. Series B Preferred * 229,479 — — — — 194,281 423,760 7,039,203 Hera Systems, Inc. Series B Warrants * 202,296 — — — — 171,469 373,765 6,214,922 Hera Systems, Inc. Series B Warrants * 170,888 — — — — 144,847 315,735 5,250,000 Hera Systems, Inc. Series B Warrants * 22,785 — — — — 19,313 42,098 700,000 Hera Systems, Inc. Series B Warrants * 398,738 — — — — 337,977 736,715 12,250,000 IntraOp Medical Corp. Convertible Note * 1,000,000 — (29,178 ) — — (254,240 ) 745,760 1,000,000 IntraOp Medical Corp. Convertible Note * 500,000 — (141,630 ) — — (127,120 ) 372,880 500,000 IntraOp Medical Corp. Convertible Note * 1,000,000 — (105,249 ) — — (254,240 ) 745,760 1,000,000 IntraOp Medical Corp. Convertible Note * 500,000 — (111,390 ) — — (127,120 ) 372,880 500,000 42 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD IntraOp Medical Corp. Convertible Note * $ 500,000 $ — $ (421 ) $ — $ — $ (127,120 ) $ 372,880 500,000 IntraOp Medical Corp. Convertible Note * 3,000,000 — 58,522 — — (762,720 ) 2,237,280 3,000,000 IntraOp Medical Corp. Convertible Note * 1,000,000 — (296,025 ) — — (254,240 ) 745,760 1,000,000 IntraOp Medical Corp. Convertible Note * 500,000 — (178,884 ) — — (127,120 ) 372,880 500,000 IntraOp Medical Corp. Convertible Note * 10,961,129 — (5,721,295 ) — — (2,786,757 ) 8,174,372 10,961,129 IntraOp Medical Corp. Convertible Note * 1,300,000 — (542,140 ) — — (330,512 ) 969,488 1,300,000 IntraOp Medical Corp. Convertible Note * 500,000 — (183,777 ) — — (127,120 ) 372,880 500,000 IntraOp Medical Corp. Convertible Note * 500,000 — (34,726 ) — — (127,120 ) 372,880 500,000 IntraOp Medical Corp. Convertible Note * — 350,000 — — — (88,984 ) 261,016 350,000 IntraOp Medical Corp. Convertible Note * — 700,000 — — — (177,968 ) 522,032 700,000 IntraOp Medical Corp. Convertible Note * 500,000 — (20,753 ) — — (127,120 ) 372,880 500,000 IntraOp Medical Corp. Convertible Note * 500,000 — (17,877 ) — — (127,120 ) 372,880 500,000 IntraOp Medical Corp. Convertible Note * — 150,000 — — — (38,136 ) 111,864 150,000 IntraOp Medical Corp. Convertible Note * 500,000 — (6,781 ) — — (127,120 ) 372,880 500,000 IntraOp Medical Corp. Convertible Note * — 200,000 — — — (50,848 ) 149,152 200,000 43 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD IntraOp Medical Corp. Convertible Note * $ 500,000 $ — $ (10,274 ) $ — $ — $ (127,120 ) $ 372,880 500,000 IntraOp Medical Corp. Convertible Note * 400,000 — (104,983 ) — — (101,696 ) 298,304 400,000 IntraOp Medical Corp. Convertible Note * 750,000 — (157,131 ) — — (190,680 ) 559,320 750,000 IntraOp Medical Corp. Series C Preferred * 670,062 — — — — (670,062 ) — 26,856,187 IntraOp Medical Corp. Term Note * 2,000,000 — 39,452 — — (508,480 ) 1,491,520 2,000,000 Pivotal Systems Corp. CDI * 9,287,771 — — (2,107,070 ) 2,097,196 (9,277,897 ) — — Revasum, Inc. CDI * 21,466,824 2,735 — (3,100,196 ) (1,146,583 ) (14,169,739 ) 3,053,041 39,774,889 Silicon Genesis Corp. Common Stock * 277 — — — — (166 ) 111 921,892 Silicon Genesis Corp. Common Warrants * 3 — — — — (2 ) 1 37,982 Silicon Genesis Corp. Series 1-D Preferred * 5,275 — — — — (2,637 ) 2,638 850,830 Silicon Genesis Corp. Series 1-F Preferred * 100,187 — — — — (28,194 ) 71,993 912,453 Silicon Genesis Corp. Series 1-G Preferred * 439,206 — — — — (126,731 ) 312,475 48,370,793 Silicon Genesis Corp. Series 1-H Preferred * 50,277 — — — — (14,162 ) 36,115 837,942 Silicon Genesis Corp. Series 1-E Preferred * 453,506 — — — — (127,210 ) 326,296 5,704,480 Silicon Genesis Corp. Series 1-C Preferred Stock * 1,990 — — — — (970 ) 1,020 82,914 SVXR, Inc. Series A Preferred Stock — — — — (4,082,192 ) 4,082,192 — — 44 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD UCT Coatings, Inc. Common Stock $ 613,650 $ — $ — $ — $ — $ (234,000 ) $ 379,650 1,500,000 Wrightspeed, Inc. Common Stock * 1,126 — — — — (559 ) 567 69,102 Wrightspeed, Inc. Convertible Note * 300,000 — (10,100 ) — — (162,000 ) 138,000 300,000 Wrightspeed, Inc. Convertible Note * 400,000 — (51,807 ) — — (216,000 ) 184,000 400,000 Wrightspeed, Inc. Convertible Note * 1,000,000 — (24,333 ) — — (540,000 ) 460,000 1,000,000 Wrightspeed, Inc. Convertible Note * 1,000,000 — (13,000 ) — — (540,000 ) 460,000 1,000,000 Wrightspeed, Inc. Convertible Note * 1,000,000 — (1,333 ) — — (540,000 ) 460,000 1,000,000 Wrightspeed, Inc. Convertible Note * 700,000 — (20,533 ) — — (378,000 ) 322,000 700,000 Wrightspeed, Inc. Convertible Note * — 200,000 — — — (108,000 ) 92,000 200,000 Wrightspeed, Inc. Convertible Note * — 185,000 — — — (99,900 ) 85,100 185,000 Wrightspeed, Inc. Convertible Note * 1,400,000 — (145,600 ) — — (756,000 ) 644,000 1,400,000 Wrightspeed, Inc. Convertible Note * 1,200,000 — (105,600 ) — — (648,000 ) 552,000 1,200,000 Wrightspeed, Inc. Convertible Note * 1,000,000 — (76,000 ) — — (540,000 ) 460,000 1,000,000 Wrightspeed, Inc. Convertible Note * 1,000,000 — (64,355 ) — — (540,000 ) 460,000 1,000,000 Wrightspeed, Inc. Convertible Note * 1,000,000 — (53,000 ) — — (540,000 ) 460,000 1,000,000 Wrightspeed, Inc. Convertible Note * 1,050,000 — (159,157 ) — — (567,000 ) 483,000 1,050,000 Wrightspeed, Inc. Convertible Note * 400,000 — (56,294 ) — — (216,000 ) 184,000 400,000 Wrightspeed, Inc. Convertible Note * 900,000 — (147,525 ) — — (486,000 ) 414,000 900,000 Wrightspeed, Inc. Convertible Note * 1,000,000 — (45,000 ) — — (540,000 ) 460,000 1,000,000 Wrightspeed, Inc. Convertible Note * 750,000 — (131,069 ) — — (405,000 ) 345,000 750,000 Wrightspeed, Inc. Convertible Note * 4,929,015 — (1,625,767 ) — — (2,661,668 ) 2,267,347 4,929,015 Wrightspeed, Inc. Convertible Note * — 65,000 — — — (35,100 ) 29,900 65,000 45 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Wrightspeed, Inc. Convertible Note * $ — $ 250,000 $ — $ — $ — $ (135,000 ) $ 115,000 250,000 Wrightspeed, Inc. Convertible Note * — 250,000 — — — (135,000 ) 115,000 250,000 Wrightspeed, Inc. Convertible Note * — 250,000 — — — (135,000 ) 115,000 250,000 Wrightspeed, Inc. Convertible Note * — 250,000 — — — (135,000 ) 115,000 250,000 Wrightspeed, Inc. Convertible Note * — 250,000 — — — (135,000 ) 115,000 250,000 Wrightspeed, Inc. Convertible Note * — 250,000 — — — (135,000 ) 115,000 250,000 Wrightspeed, Inc. Convertible Note * — 250,000 — — — (135,000 ) 115,000 250,000 Wrightspeed, Inc. Convertible Note * 375,000 — (50,813 ) — — (202,500 ) 172,500 375,000 Wrightspeed, Inc. Convertible Note * 2,000,000 — (250,063 ) — — (1,080,000 ) 920,000 2,000,000 Wrightspeed, Inc. Series AA Preferred * 1,777,068 — — — — (702,082 ) 1,074,986 60,733,693 Wrightspeed, Inc. Series AA Warrants * 7,500 — — — — (4,086 ) 3,414 609,756 Total Affiliates and Controlled Investments $ 90,118,729 $ (10,174,101 ) $ (3,131,579 ) $ (40,776,553 ) $ 45,361,066 Total Affiliates 613,650 — (4,082,192 ) 3,848,192 379,650 Total Controlled Investments $ 89,505,079 $ (10,174,101 ) $ 950,613 $ (44,624,745 ) $ 44,981,416 * Controlled Investments. (1) CDI CHESS Depositary Interests As of September 30, 2022, Kevin Landis, the Company’s Chairman, President and Chief Executive Officer, represented the Company and sat on the boards of directors of Hera Systems, Inc.; IntraOp Medical Corp.; Revasum, Inc.; Silicon Genesis Corp.; and Wrightspeed, Inc. Serving on boards of directors of portfolio companies may cause conflicts of interest. The Advisor has adopted various procedures to ensure that the Company will not be unfavorably affected by these potential conflicts. |
MARKET DISRUPTION AND GEOPOLITI
MARKET DISRUPTION AND GEOPOLITICAL RISKS | 9 Months Ended |
Sep. 30, 2022 | |
Market Disruption And Geopolitical Risks | |
MARKET DISRUPTION AND GEOPOLITICAL RISKS | NOTE 11. MARKET DISRUPTION AND GEOPOLITICAL RISKS Certain local, regional or global events such as war, acts of terrorism, the spread of infectious illness or other public health issues, or other events could have a significant impact on a security or instrument. Since 2020, the novel strain of coronavirus (COVID-19) has negatively affected the worldwide economy, as well as the economies of individual countries, the financial health of individual companies and the market in general in significant and unforeseen ways. Following Russia’s large-scale invasion of Ukraine, the President of the United States signed an Executive Order in February 2022 prohibiting U.S. persons from entering transactions with the Central Bank of Russia and Executive Orders in March 2022 prohibiting U.S. persons from importing oil and gas from Russia as well as other popular Russian exports, such as diamonds, seafood and vodka. The duration of the coronavirus outbreak and the Russian-Ukraine conflict could adversely affect the Company’s performance. The ultimate impact of COVID-19 and Russia invasion on the financial performance of the Company’s investments is not reasonably estimable at this time. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 9 Months Ended |
Sep. 30, 2022 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 12. SUBSEQUENT EVENTS Management has evaluated the impact of all subsequent events on the Company through the date the financial statements were issued, and has determined that there were no subsequent events requiring recognition or disclosure in the financial statements. |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
BASIS OF PRESENTATION | BASIS OF PRESENTATION Financial Services—Investment Companies Under the 1940 Act, ASC 946, and the regulations pursuant to Article 6 of Regulation S-X, we are precluded from consolidating any entity other than another investment company or an operating company which provides substantially all of its services to benefit us. Consequentially, as of December 31, 2018, the Company consolidated some special purpose entities. These special purpose entities only hold investments of the Company and have no other significant asset and liabilities. All significant intercompany transactions and balances have been eliminated in consolidation. |
USE OF ESTIMATES | USE OF ESTIMATES |
PORTFOLIO INVESTMENT VALUATIONS | PORTFOLIO INVESTMENT VALUATIONS 40.0 |
CASH AND CASH EQUIVALENTS | CASH AND CASH EQUIVALENTS |
RESTRICTED SECURITIES | RESTRICTED SECURITIES 42,408,025 59,744,294 |
INCOME RECOGNITION | INCOME RECOGNITION 10.4 16.3 |
SHARE VALUATION | SHARE VALUATION |
REALIZED GAIN OR LOSS AND UNREALIZED APPRECIATION OR DEPRECIATION OF PORTFOLIO INVESTMENTS | REALIZED GAIN OR LOSS AND UNREALIZED APPRECIATION OR DEPRECIATION OF PORTFOLIO INVESTMENTS |
INCOME TAXES | INCOME TAXES |
FOREIGN CURRENCY TRANSLATION | FOREIGN CURRENCY TRANSLATION |
SECURITIES TRANSACTIONS | SECURITIES TRANSACTIONS i.e. |
CONCENTRATION OF CREDIT RISK | CONCENTRATION OF CREDIT RISK |
OPTIONS | OPTIONS Premiums received from writing options that expire unexercised are treated by the Company on the expiration date as realized gains from investments. The difference between the premium and the amount paid on effecting a closing purchase transaction, including brokerage commissions, is also treated as a realized gain, or, if the premium is less than the amount paid for the closing purchase transaction, as a realized loss. If a call option is exercised, the premium is added to the proceeds from the sale of the underlying security or currency in determining whether the Company has realized a gain or loss. The Company as writer of an option bears the market risk of an unfavorable change in the price of the security underlying the written option. The average quarterly volume of the Company’s derivatives during the nine months ended September 30, 2022 is as follows: Schedule of derivatives PURCHASED OPTIONS WARRANTS WRITTEN OPTIONS Firsthand Technology Value Fund, Inc. — 843,845 — |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
Schedule of derivatives | Schedule of derivatives PURCHASED OPTIONS WARRANTS WRITTEN OPTIONS Firsthand Technology Value Fund, Inc. — 843,845 — |
FAIR VALUE (Tables)
FAIR VALUE (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Fair Value Disclosures [Abstract] | |
Schedule of fair value of net asset | Schedule of fair value of net asset ASSETS LEVEL 1 LEVEL 2 OTHER LEVEL 3 SIGNIFICANT Common Stocks Advanced Materials $ — $ — $ 379,650 Automotive — — 567 Equipment Leasing — — 16,220 Intellectual Property — — 111 Semiconductor Equipment 3,053,041 — — Total Common Stocks 3,053,041 — 396,548 Preferred Stocks Aerospace — — 597,131 Automotive — — 1,074,986 Equipment Leasing — — 1,183,820 Intellectual Property — — 750,537 Total Preferred Stocks — — 3,606,474 Asset Derivatives * Equity Contracts — — 1,471,728 Total Asset Derivatives — — 1,471,728 Convertible Notes Advanced Materials — — 100,000 Aerospace — — 5,235,000 Automotive — — 10,857,847 Medical Devices — — 20,740,428 Total Convertible Notes — — 36,933,275 Mutual Funds 1,142,833 — — Total $ 4,195,874 $ — $ 42,408,025 * Asset derivatives include warrants. |
Schedule of unobservable inputs of fair value | Schedule of unobservable inputs of fair value INVESTMENTS AT FAIR BALANCE NET NET SALES/ NET REALIZED NET UNREALIZED (1) TRANSFERS BALANCE Common Stocks Advanced Materials $ 613,650 $ — $ — $ — $ (234,000 ) $ — $ 379,650 Automotive 1,126 — — — (559 ) — 567 Equipment Leasing 31,490 — — — (15,270 ) — 16,220 Intellectual Property 277 — — — (166 ) — 111 Total Common Stocks 646,543 — — — (249,995 ) — 396,548 Preferred Stocks Aerospace 324,245 — — — 272,886 — 597,131 Automotive 1,777,068 — — — (702,082 ) — 1,074,986 Equipment Leasing 1,898,420 — (100,000 ) — (614,600 ) — 1,183,820 Intellectual Property 1,050,442 — — — (299,905 ) — 750,537 Medical Devices 670,062 — — — (670,062 ) — — Semiconductor Equipment 280,160 — — (4,082,192 ) 3,802,032 — — Total Preferred Stocks 6,000,397 — (100,000 ) (4,082,192 ) 1,788,269 — 3,606,474 Asset Derivatives Equity Contracts 802,210 — — — 669,518 — 1,471,728 Total Asset Derivatives 802,210 — — — 669,518 — 1,471,728 Convertible Notes Advanced Materials 100,000 — — — — — 100,000 Aerospace 4,380,000 855,000 — — — — 5,235,000 Automotive 21,404,015 2,200,000 — — (12,746,168 ) — 10,857,847 Medical Devices 26,411,129 1,400,000 — — (7,070,701 ) — 20,740,428 Total Convertible Notes 52,295,144 4,455,000 — — (19,816,869 ) — 36,933,275 Total $ 59,744,294 $ 4,455,000 $ (100,000 ) $ (4,082,192 ) $ (17,609,077 ) $ — $ 42,408,025 (1) The net change in unrealized appreciation (depreciation) from Level 3 instruments held as of September 30, 2022 was $(21,691,268). |
Schedule of unobservable inputs fair value measurements | Schedule of unobservable inputs fair value measurements FAIR VALUATION TECHNIQUES UNOBSERVABLE INPUTS RANGE Direct venture capital investments: Advanced Materials $ 0.5 Market Comparable Companies Option Pricing Model EBITDA Multiple Revenue Multiple Years to Maturity Volatility Risk-Free Rate Discount for Lack of Marketability 4.9x - 6.4x (5.7x) 0.6x – 0.6x (0.6x) 5 years (5 years) 50.0% (50.0%) 4.06% (4.06%) 22.7% (22.7%) Direct venture capital investments: Aerospace $ 7.3 Market Comparable Companies Option Pricing Model EBITDA Multiple Years to Maturity Volatility Risk-Free Rate 7.0x – 10.2x (7.9x) 5 years (5 years) 60.0% (60.0%) 4.06% (4.06%) Direct venture capital investments: Automotive $ 11.9 Prior Transaction Analysis Option Pricing Model Probability-Weighted Expected Return Method Years to Maturity Volatility Risk-Free Rate Discount for Lack of Marketability Going Concern Probability 5 years (5 years) 50.0% (50.0%) 4.06% (4.06%) 0.0% - 22.7% (0.0%) 10% (10%) Direct venture capital investments: Equipment Leasing $ 1.2 Discounted Cash Flow Option Pricing Model Weighted Average Cost of Capital Years to Maturity Volatility Risk-Free Rate 20.0% (20.0%) 5 years (5 years) 50.0% (50.0%) 4.06% (4.06%) Direct venture capital investments: Intellectual Property $ 0.8 Discounted Cash Flow Option Pricing Model Weighted Average Cost of Capital Years to Maturity Volatility Risk-Free Rate Discount for Lack of Marketability 12.5% (12.5%) 5 years (5 years) 55.0% (55.0%) 4.06% (4.06%) 0.0% - 24.3% (0.0%) Direct venture capital investments: Medical Devices $ 20.7 Market Comparable Companies Revenue Multiple 1.9x – 2.2x (2.1x) |
FEDERAL INCOME TAXES (Tables)
FEDERAL INCOME TAXES (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Income Tax Disclosure [Abstract] | |
Schedule of federal income tax cost of portfolio investments | Schedule of federal income tax cost of portfolio investments FEDERAL INCOME Gross unrealized appreciation $ 1,471,727 Gross unrealized depreciation (96,628,458 ) Net unrealized (depreciation) $ (95,156,731 ) Federal income tax cost, Investments $ 141,760,630 |
Schedule of income tax provision | Schedule of income tax provision Deferred tax (expense)/benefit Federal $ — State — Total deferred tax (expense)/benefit $ — |
Schedule of deferred tax assets and liabilities | Schedule of deferred tax assets and liabilities AMOUNT Deferred tax assets: Net operating loss carryforward $ 261,739 Capital loss carryforward 6,084,731 Net unrealized losses (gains) on investment securities 15,137,185 Total deferred tax assets 21,483,655 Valuation allowance (21,483,655 ) Net $ — |
Schedule of effective tax rate and statutory federal income tax rate | Schedule of effective tax rate and statutory federal income tax rate THREE MONTHS ENDED THREE MONTHS ENDED NINE MONTHS ENDED NINE MONTHS ENDED Effective tax rate 0% 0% 0% 0% Statutory federal income tax rate 21% 21% 21% 21% |
Schedule of net capital loss carryforwards | Schedule of net capital loss carryforwards EXPIRATION DATE AMOUNT 12/31/24 $ 14,230,073 12/31/25 7,516,642 Total $ 21,746,715 |
INVESTMENT TRANSACTIONS (Tables
INVESTMENT TRANSACTIONS (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Investments, All Other Investments [Abstract] | |
Schedule of investment transactions | Schedule of investment transactions PURCHASES AND SALES Purchases of investment securities $ 2,734 Proceeds from sales and maturities of investment securities $ 5,307,261 |
INVESTMENTS IN AFFILIATES AND_2
INVESTMENTS IN AFFILIATES AND CONTROLLED INVESTMENTS (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Investments in and Advances to Affiliates [Abstract] | |
Schedule of investments in affiliates and controlled investments | Schedule of investments in affiliates and controlled investments AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD EQX Capital, Inc. Common Stock * $ 31,490 $ — $ — $ — $ — $ (15,270 ) $ 16,220 100,000 EQX Capital, Inc. Series A Preferred Stock * 1,898,420 — — (100,000 ) — (614,600 ) 1,183,820 2,200,000 Hera Systems, Inc. Convertible Note * 40,000 — 3,533 — — — 40,000 40,000 Hera Systems, Inc. Convertible Note * — 100,000 2,222 — — — 100,000 100,000 Hera Systems, Inc. Convertible Note * 200,000 — 15,696 — — — 200,000 200,000 Hera Systems, Inc. Convertible Note * — 55,000 2,200 — — — 55,000 55,000 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Hera Systems, Inc. Convertible Note * $ 150,000 $ — $ 12,334 $ — $ — $ — $ 150,000 150,000 Hera Systems, Inc. Convertible Note * 150,000 — 12,626 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * 150,000 — 11,527 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * — 70,000 312 (70,000 ) — — — — Hera Systems, Inc. Convertible Note * 150,000 — 11,375 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * 150,000 — 11,375 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * 150,000 — 11,375 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * 150,000 — 11,658 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * — 90,000 2,375 — — — 90,000 90,000 Hera Systems, Inc. Convertible Note * 200,000 — 17,306 — — — 200,000 200,000 Hera Systems, Inc. Convertible Note * — 75,000 2,354 — — — 75,000 75,000 Hera Systems, Inc. Convertible Note * — 75,000 3,292 — — — 75,000 75,000 Hera Systems, Inc. Convertible Note * — 75,000 2,667 — — — 75,000 75,000 Hera Systems, Inc. Convertible Note * — 150,000 9,708 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * 500,000 — 52,986 — — — 500,000 500,000 Hera Systems, Inc. Convertible Note * 50,000 — 4,141 — — — 50,000 50,000 Hera Systems, Inc. Convertible Note * 150,000 — 12,038 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * 150,000 — 12,178 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * — 70,000 3,325 — — — 70,000 70,000 Hera Systems, Inc. Convertible Note * 250,000 — 20,881 — — — 250,000 250,000 Hera Systems, Inc. Convertible Note * 500,000 — 55,470 — — — 500,000 500,000 Hera Systems, Inc. Convertible Note * 250,000 — 20,880 — — — 250,000 250,000 41 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Hera Systems, Inc. Convertible Note * $ 250,000 $ — $ 22,369 $ — $ — $ — $ 250,000 250,000 Hera Systems, Inc. Convertible Note * 220,000 — 18,757 — — — 220,000 220,000 Hera Systems, Inc. Convertible Note * 20,000 — 1,748 — — — 20,000 20,000 Hera Systems, Inc. Convertible Note * 150,000 — 11,375 — — — 150,000 150,000 Hera Systems, Inc. Convertible Note * — 90,000 4,650 — — — 90,000 90,000 Hera Systems, Inc. Convertible Note * — 75,000 4,250 — — — 75,000 75,000 Hera Systems, Inc. Convertible Note * 250,000 — 20,881 — — — 250,000 250,000 Hera Systems, Inc. Convertible Note * 150,000 — 11,924 — — — 150,000 150,000 Hera Systems, Inc. Series C Preferred * 86,390 — — — — 73,140 159,530 2,650,000 Hera Systems, Inc. Series A Preferred * 8,377 — — — — 5,464 13,841 3,642,324 Hera Systems, Inc. Series B Preferred * 229,479 — — — — 194,281 423,760 7,039,203 Hera Systems, Inc. Series B Warrants * 202,296 — — — — 171,469 373,765 6,214,922 Hera Systems, Inc. Series B Warrants * 170,888 — — — — 144,847 315,735 5,250,000 Hera Systems, Inc. Series B Warrants * 22,785 — — — — 19,313 42,098 700,000 Hera Systems, Inc. Series B Warrants * 398,738 — — — — 337,977 736,715 12,250,000 IntraOp Medical Corp. Convertible Note * 1,000,000 — (29,178 ) — — (254,240 ) 745,760 1,000,000 IntraOp Medical Corp. Convertible Note * 500,000 — (141,630 ) — — (127,120 ) 372,880 500,000 IntraOp Medical Corp. Convertible Note * 1,000,000 — (105,249 ) — — (254,240 ) 745,760 1,000,000 IntraOp Medical Corp. Convertible Note * 500,000 — (111,390 ) — — (127,120 ) 372,880 500,000 42 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD IntraOp Medical Corp. Convertible Note * $ 500,000 $ — $ (421 ) $ — $ — $ (127,120 ) $ 372,880 500,000 IntraOp Medical Corp. Convertible Note * 3,000,000 — 58,522 — — (762,720 ) 2,237,280 3,000,000 IntraOp Medical Corp. Convertible Note * 1,000,000 — (296,025 ) — — (254,240 ) 745,760 1,000,000 IntraOp Medical Corp. Convertible Note * 500,000 — (178,884 ) — — (127,120 ) 372,880 500,000 IntraOp Medical Corp. Convertible Note * 10,961,129 — (5,721,295 ) — — (2,786,757 ) 8,174,372 10,961,129 IntraOp Medical Corp. Convertible Note * 1,300,000 — (542,140 ) — — (330,512 ) 969,488 1,300,000 IntraOp Medical Corp. Convertible Note * 500,000 — (183,777 ) — — (127,120 ) 372,880 500,000 IntraOp Medical Corp. Convertible Note * 500,000 — (34,726 ) — — (127,120 ) 372,880 500,000 IntraOp Medical Corp. Convertible Note * — 350,000 — — — (88,984 ) 261,016 350,000 IntraOp Medical Corp. Convertible Note * — 700,000 — — — (177,968 ) 522,032 700,000 IntraOp Medical Corp. Convertible Note * 500,000 — (20,753 ) — — (127,120 ) 372,880 500,000 IntraOp Medical Corp. Convertible Note * 500,000 — (17,877 ) — — (127,120 ) 372,880 500,000 IntraOp Medical Corp. Convertible Note * — 150,000 — — — (38,136 ) 111,864 150,000 IntraOp Medical Corp. Convertible Note * 500,000 — (6,781 ) — — (127,120 ) 372,880 500,000 IntraOp Medical Corp. Convertible Note * — 200,000 — — — (50,848 ) 149,152 200,000 43 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD IntraOp Medical Corp. Convertible Note * $ 500,000 $ — $ (10,274 ) $ — $ — $ (127,120 ) $ 372,880 500,000 IntraOp Medical Corp. Convertible Note * 400,000 — (104,983 ) — — (101,696 ) 298,304 400,000 IntraOp Medical Corp. Convertible Note * 750,000 — (157,131 ) — — (190,680 ) 559,320 750,000 IntraOp Medical Corp. Series C Preferred * 670,062 — — — — (670,062 ) — 26,856,187 IntraOp Medical Corp. Term Note * 2,000,000 — 39,452 — — (508,480 ) 1,491,520 2,000,000 Pivotal Systems Corp. CDI * 9,287,771 — — (2,107,070 ) 2,097,196 (9,277,897 ) — — Revasum, Inc. CDI * 21,466,824 2,735 — (3,100,196 ) (1,146,583 ) (14,169,739 ) 3,053,041 39,774,889 Silicon Genesis Corp. Common Stock * 277 — — — — (166 ) 111 921,892 Silicon Genesis Corp. Common Warrants * 3 — — — — (2 ) 1 37,982 Silicon Genesis Corp. Series 1-D Preferred * 5,275 — — — — (2,637 ) 2,638 850,830 Silicon Genesis Corp. Series 1-F Preferred * 100,187 — — — — (28,194 ) 71,993 912,453 Silicon Genesis Corp. Series 1-G Preferred * 439,206 — — — — (126,731 ) 312,475 48,370,793 Silicon Genesis Corp. Series 1-H Preferred * 50,277 — — — — (14,162 ) 36,115 837,942 Silicon Genesis Corp. Series 1-E Preferred * 453,506 — — — — (127,210 ) 326,296 5,704,480 Silicon Genesis Corp. Series 1-C Preferred Stock * 1,990 — — — — (970 ) 1,020 82,914 SVXR, Inc. Series A Preferred Stock — — — — (4,082,192 ) 4,082,192 — — 44 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD UCT Coatings, Inc. Common Stock $ 613,650 $ — $ — $ — $ — $ (234,000 ) $ 379,650 1,500,000 Wrightspeed, Inc. Common Stock * 1,126 — — — — (559 ) 567 69,102 Wrightspeed, Inc. Convertible Note * 300,000 — (10,100 ) — — (162,000 ) 138,000 300,000 Wrightspeed, Inc. Convertible Note * 400,000 — (51,807 ) — — (216,000 ) 184,000 400,000 Wrightspeed, Inc. Convertible Note * 1,000,000 — (24,333 ) — — (540,000 ) 460,000 1,000,000 Wrightspeed, Inc. Convertible Note * 1,000,000 — (13,000 ) — — (540,000 ) 460,000 1,000,000 Wrightspeed, Inc. Convertible Note * 1,000,000 — (1,333 ) — — (540,000 ) 460,000 1,000,000 Wrightspeed, Inc. Convertible Note * 700,000 — (20,533 ) — — (378,000 ) 322,000 700,000 Wrightspeed, Inc. Convertible Note * — 200,000 — — — (108,000 ) 92,000 200,000 Wrightspeed, Inc. Convertible Note * — 185,000 — — — (99,900 ) 85,100 185,000 Wrightspeed, Inc. Convertible Note * 1,400,000 — (145,600 ) — — (756,000 ) 644,000 1,400,000 Wrightspeed, Inc. Convertible Note * 1,200,000 — (105,600 ) — — (648,000 ) 552,000 1,200,000 Wrightspeed, Inc. Convertible Note * 1,000,000 — (76,000 ) — — (540,000 ) 460,000 1,000,000 Wrightspeed, Inc. Convertible Note * 1,000,000 — (64,355 ) — — (540,000 ) 460,000 1,000,000 Wrightspeed, Inc. Convertible Note * 1,000,000 — (53,000 ) — — (540,000 ) 460,000 1,000,000 Wrightspeed, Inc. Convertible Note * 1,050,000 — (159,157 ) — — (567,000 ) 483,000 1,050,000 Wrightspeed, Inc. Convertible Note * 400,000 — (56,294 ) — — (216,000 ) 184,000 400,000 Wrightspeed, Inc. Convertible Note * 900,000 — (147,525 ) — — (486,000 ) 414,000 900,000 Wrightspeed, Inc. Convertible Note * 1,000,000 — (45,000 ) — — (540,000 ) 460,000 1,000,000 Wrightspeed, Inc. Convertible Note * 750,000 — (131,069 ) — — (405,000 ) 345,000 750,000 Wrightspeed, Inc. Convertible Note * 4,929,015 — (1,625,767 ) — — (2,661,668 ) 2,267,347 4,929,015 Wrightspeed, Inc. Convertible Note * — 65,000 — — — (35,100 ) 29,900 65,000 45 AFFILIATE/ * VALUE AT PURCHASE/ INTEREST SALES/ REALIZED CHANGE IN VALUE SHARES HELD Wrightspeed, Inc. Convertible Note * $ — $ 250,000 $ — $ — $ — $ (135,000 ) $ 115,000 250,000 Wrightspeed, Inc. Convertible Note * — 250,000 — — — (135,000 ) 115,000 250,000 Wrightspeed, Inc. Convertible Note * — 250,000 — — — (135,000 ) 115,000 250,000 Wrightspeed, Inc. Convertible Note * — 250,000 — — — (135,000 ) 115,000 250,000 Wrightspeed, Inc. Convertible Note * — 250,000 — — — (135,000 ) 115,000 250,000 Wrightspeed, Inc. Convertible Note * — 250,000 — — — (135,000 ) 115,000 250,000 Wrightspeed, Inc. Convertible Note * — 250,000 — — — (135,000 ) 115,000 250,000 Wrightspeed, Inc. Convertible Note * 375,000 — (50,813 ) — — (202,500 ) 172,500 375,000 Wrightspeed, Inc. Convertible Note * 2,000,000 — (250,063 ) — — (1,080,000 ) 920,000 2,000,000 Wrightspeed, Inc. Series AA Preferred * 1,777,068 — — — — (702,082 ) 1,074,986 60,733,693 Wrightspeed, Inc. Series AA Warrants * 7,500 — — — — (4,086 ) 3,414 609,756 Total Affiliates and Controlled Investments $ 90,118,729 $ (10,174,101 ) $ (3,131,579 ) $ (40,776,553 ) $ 45,361,066 Total Affiliates 613,650 — (4,082,192 ) 3,848,192 379,650 Total Controlled Investments $ 89,505,079 $ (10,174,101 ) $ 950,613 $ (44,624,745 ) $ 44,981,416 * Controlled Investments. (1) CDI CHESS Depositary Interests |
SUMMARY OF SIGNIFICANT ACCOUN_4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) | 9 Months Ended |
Sep. 30, 2022 USD ($) | |
Accounting Policies [Abstract] | |
PURCHASED OPTIONS (CONTRACTS) | $ 0 |
WARRANTS (NOTIONAL VALUE) | 843,845 |
WRITTEN OPTIONS (CONTRACTS) | $ 0 |
SUMMARY OF SIGNIFICANT ACCOUN_5
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2022 | Dec. 31, 2021 | |
Accounting Policies [Abstract] | |||
Venture capital investments | $ 40,000 | ||
Restricted securities | $ 42,408,025 | 42,408,025 | $ 59,744,294 |
Interest adjustment | $ 10,400 | $ 16,300 |
INVESTMENT MANAGEMENT FEE (Deta
INVESTMENT MANAGEMENT FEE (Details Narrative) | Sep. 30, 2022 |
Investment Management Fee | |
Annual rate | 2% |
FAIR VALUE (Details)
FAIR VALUE (Details) - USD ($) | Sep. 30, 2022 | Dec. 31, 2021 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | $ 47,805,453 | $ 102,678,250 | |
Fair Value, Inputs, Level 1 [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 4,195,874 | ||
Fair Value, Inputs, Level 1 [Member] | Convertible Notes [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 1 [Member] | Mutual Funds [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 1,142,833 | ||
Fair Value, Inputs, Level 1 [Member] | Advanced Materials [Member] | Convertible Notes [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 1 [Member] | Automotive [Member] | Convertible Notes [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 1 [Member] | Aerospace [Member] | Convertible Notes [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 1 [Member] | Medical Devices [Member] | Convertible Notes [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 3,053,041 | ||
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Intellectual Property [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Advanced Materials [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Automotive [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Equipment Leasing [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 1 [Member] | Common Stock [Member] | Semiconductor Equipment [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 3,053,041 | ||
Fair Value, Inputs, Level 1 [Member] | Preferred Stock [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 1 [Member] | Preferred Stock [Member] | Equity Contracts [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | [1] | ||
Fair Value, Inputs, Level 1 [Member] | Preferred Stock [Member] | Asset Derivatives [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 1 [Member] | Preferred Stock [Member] | Intellectual Property [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 1 [Member] | Preferred Stock [Member] | Automotive [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 1 [Member] | Preferred Stock [Member] | Equipment Leasing [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 1 [Member] | Preferred Stock [Member] | Aerospace [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Convertible Notes [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Mutual Funds [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Advanced Materials [Member] | Convertible Notes [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Automotive [Member] | Convertible Notes [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Aerospace [Member] | Convertible Notes [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Medical Devices [Member] | Convertible Notes [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Intellectual Property [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Advanced Materials [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Automotive [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Equipment Leasing [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Common Stock [Member] | Semiconductor Equipment [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Preferred Stock [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Preferred Stock [Member] | Equity Contracts [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | [1] | ||
Fair Value, Inputs, Level 2 [Member] | Preferred Stock [Member] | Asset Derivatives [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Preferred Stock [Member] | Intellectual Property [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Preferred Stock [Member] | Automotive [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Preferred Stock [Member] | Equipment Leasing [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 2 [Member] | Preferred Stock [Member] | Aerospace [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 3 [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 42,408,025 | ||
Fair Value, Inputs, Level 3 [Member] | Convertible Notes [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 36,933,275 | ||
Fair Value, Inputs, Level 3 [Member] | Mutual Funds [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 3 [Member] | Advanced Materials [Member] | Convertible Notes [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 100,000 | ||
Fair Value, Inputs, Level 3 [Member] | Automotive [Member] | Convertible Notes [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 10,857,847 | ||
Fair Value, Inputs, Level 3 [Member] | Aerospace [Member] | Convertible Notes [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 5,235,000 | ||
Fair Value, Inputs, Level 3 [Member] | Medical Devices [Member] | Convertible Notes [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 20,740,428 | ||
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 396,548 | ||
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Intellectual Property [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 111 | ||
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Advanced Materials [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 379,650 | ||
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Automotive [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 567 | ||
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Equipment Leasing [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 16,220 | ||
Fair Value, Inputs, Level 3 [Member] | Common Stock [Member] | Semiconductor Equipment [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | |||
Fair Value, Inputs, Level 3 [Member] | Preferred Stock [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 3,606,474 | ||
Fair Value, Inputs, Level 3 [Member] | Preferred Stock [Member] | Equity Contracts [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | [1] | 1,471,728 | |
Fair Value, Inputs, Level 3 [Member] | Preferred Stock [Member] | Asset Derivatives [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 1,471,728 | ||
Fair Value, Inputs, Level 3 [Member] | Preferred Stock [Member] | Intellectual Property [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 750,537 | ||
Fair Value, Inputs, Level 3 [Member] | Preferred Stock [Member] | Automotive [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 1,074,986 | ||
Fair Value, Inputs, Level 3 [Member] | Preferred Stock [Member] | Equipment Leasing [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | 1,183,820 | ||
Fair Value, Inputs, Level 3 [Member] | Preferred Stock [Member] | Aerospace [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Assets | $ 597,131 | ||
[1]Asset derivatives include warrants. |
FAIR VALUE (Details 1)
FAIR VALUE (Details 1) | 9 Months Ended |
Sep. 30, 2022 USD ($) | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | $ 59,744,294 |
NET PURCHASES/CONVERSIONS | 4,455,000 |
NET SALES/CONVERSIONS | (100,000) |
NET REALIZED GAINS/(LOSSES) | (4,082,192) |
NET UNREALIZED APPRECIATION (DEPRECIATION) | (17,609,077) |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 42,408,025 |
Convertible Notes [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 52,295,144 |
NET PURCHASES/CONVERSIONS | 4,455,000 |
NET SALES/CONVERSIONS | |
NET REALIZED GAINS/(LOSSES) | |
NET UNREALIZED APPRECIATION (DEPRECIATION) | (19,816,869) |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 36,933,275 |
Advanced Materials [Member] | Convertible Notes [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 100,000 |
NET PURCHASES/CONVERSIONS | |
NET SALES/CONVERSIONS | |
NET REALIZED GAINS/(LOSSES) | |
NET UNREALIZED APPRECIATION (DEPRECIATION) | |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 100,000 |
Automotive [Member] | Convertible Notes [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 21,404,015 |
NET PURCHASES/CONVERSIONS | 2,200,000 |
NET SALES/CONVERSIONS | |
NET REALIZED GAINS/(LOSSES) | |
NET UNREALIZED APPRECIATION (DEPRECIATION) | (12,746,168) |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 10,857,847 |
Aerospace [Member] | Convertible Notes [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 4,380,000 |
NET PURCHASES/CONVERSIONS | 855,000 |
NET SALES/CONVERSIONS | |
NET REALIZED GAINS/(LOSSES) | |
NET UNREALIZED APPRECIATION (DEPRECIATION) | |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 5,235,000 |
Medical Devices [Member] | Convertible Notes [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 26,411,129 |
NET PURCHASES/CONVERSIONS | 1,400,000 |
NET SALES/CONVERSIONS | |
NET REALIZED GAINS/(LOSSES) | |
NET UNREALIZED APPRECIATION (DEPRECIATION) | (7,070,701) |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 20,740,428 |
Common Stock [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 646,543 |
NET PURCHASES/CONVERSIONS | |
NET SALES/CONVERSIONS | |
NET REALIZED GAINS/(LOSSES) | |
NET UNREALIZED APPRECIATION (DEPRECIATION) | (249,995) |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 396,548 |
Common Stock [Member] | Intellectual Property [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 277 |
NET PURCHASES/CONVERSIONS | |
NET SALES/CONVERSIONS | |
NET REALIZED GAINS/(LOSSES) | |
NET UNREALIZED APPRECIATION (DEPRECIATION) | (166) |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 111 |
Common Stock [Member] | Advanced Materials [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 613,650 |
NET PURCHASES/CONVERSIONS | 0 |
NET SALES/CONVERSIONS | 0 |
NET REALIZED GAINS/(LOSSES) | 0 |
NET UNREALIZED APPRECIATION (DEPRECIATION) | (234,000) |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 379,650 |
Common Stock [Member] | Automotive [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 1,126 |
NET PURCHASES/CONVERSIONS | |
NET SALES/CONVERSIONS | |
NET REALIZED GAINS/(LOSSES) | |
NET UNREALIZED APPRECIATION (DEPRECIATION) | (559) |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 567 |
Common Stock [Member] | Equipment Leasing [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 31,490 |
NET PURCHASES/CONVERSIONS | |
NET SALES/CONVERSIONS | |
NET REALIZED GAINS/(LOSSES) | |
NET UNREALIZED APPRECIATION (DEPRECIATION) | (15,270) |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 16,220 |
Preferred Stock [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 6,000,397 |
NET PURCHASES/CONVERSIONS | |
NET SALES/CONVERSIONS | (100,000) |
NET REALIZED GAINS/(LOSSES) | (4,082,192) |
NET UNREALIZED APPRECIATION (DEPRECIATION) | 1,788,269 |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 3,606,474 |
Preferred Stock [Member] | Equity Contracts [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 802,210 |
NET PURCHASES/CONVERSIONS | |
NET SALES/CONVERSIONS | |
NET REALIZED GAINS/(LOSSES) | |
NET UNREALIZED APPRECIATION (DEPRECIATION) | 669,518 |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 1,471,728 |
Preferred Stock [Member] | Asset Derivatives [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 802,210 |
NET PURCHASES/CONVERSIONS | |
NET SALES/CONVERSIONS | |
NET REALIZED GAINS/(LOSSES) | |
NET UNREALIZED APPRECIATION (DEPRECIATION) | 669,518 |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 1,471,728 |
Preferred Stock [Member] | Intellectual Property [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 1,050,442 |
NET PURCHASES/CONVERSIONS | |
NET SALES/CONVERSIONS | |
NET REALIZED GAINS/(LOSSES) | |
NET UNREALIZED APPRECIATION (DEPRECIATION) | (299,905) |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 750,537 |
Preferred Stock [Member] | Automotive [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 1,777,068 |
NET PURCHASES/CONVERSIONS | |
NET SALES/CONVERSIONS | |
NET REALIZED GAINS/(LOSSES) | |
NET UNREALIZED APPRECIATION (DEPRECIATION) | (702,082) |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 1,074,986 |
Preferred Stock [Member] | Equipment Leasing [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 1,898,420 |
NET PURCHASES/CONVERSIONS | |
NET SALES/CONVERSIONS | (100,000) |
NET REALIZED GAINS/(LOSSES) | |
NET UNREALIZED APPRECIATION (DEPRECIATION) | (614,600) |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 1,183,820 |
Preferred Stock [Member] | Aerospace [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 324,245 |
NET PURCHASES/CONVERSIONS | |
NET SALES/CONVERSIONS | |
NET REALIZED GAINS/(LOSSES) | |
NET UNREALIZED APPRECIATION (DEPRECIATION) | 272,886 |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | 597,131 |
Preferred Stock [Member] | Medical Devices [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 670,062 |
NET PURCHASES/CONVERSIONS | |
NET SALES/CONVERSIONS | |
NET REALIZED GAINS/(LOSSES) | |
NET UNREALIZED APPRECIATION (DEPRECIATION) | (670,062) |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE | |
Preferred Stock [Member] | Semiconductor Equipment [Member] | |
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
BEGINNING BALANCE | 280,160 |
NET PURCHASES/CONVERSIONS | |
NET SALES/CONVERSIONS | |
NET REALIZED GAINS/(LOSSES) | (4,082,192) |
NET UNREALIZED APPRECIATION (DEPRECIATION) | 3,802,032 |
TRANSFERS IN (OUT) OF LEVEL 3 | |
ENDING BALANCE |
FAIR VALUE (Details 2)
FAIR VALUE (Details 2) $ in Thousands | Sep. 30, 2022 USD ($) |
Intellectual Property [Member] | |
Property, Plant and Equipment [Line Items] | |
FAIR VALUE | $ 800 |
Advanced Materials [Member] | |
Property, Plant and Equipment [Line Items] | |
FAIR VALUE | 500 |
Aerospace [Member] | |
Property, Plant and Equipment [Line Items] | |
FAIR VALUE | 7,300 |
Automotive [Member] | |
Property, Plant and Equipment [Line Items] | |
FAIR VALUE | 11,900 |
Equipment Leasing [Member] | |
Property, Plant and Equipment [Line Items] | |
FAIR VALUE | 1,200 |
Medical Devices [Member] | |
Property, Plant and Equipment [Line Items] | |
FAIR VALUE | $ 20,700 |
FEDERAL INCOME TAXES (Details)
FEDERAL INCOME TAXES (Details) | Sep. 30, 2022 USD ($) |
Income Tax Disclosure [Abstract] | |
Gross unrealized appreciation | $ 1,471,727 |
Gross unrealized depreciation | (96,628,458) |
Net unrealized (depreciation) | (95,156,731) |
Federal income tax cost, Investments | $ 141,760,630 |
FEDERAL INCOME TAXES (Details 1
FEDERAL INCOME TAXES (Details 1) | 9 Months Ended |
Sep. 30, 2022 USD ($) | |
Income Tax Disclosure [Abstract] | |
Federal | |
State | |
Total deferred tax (expense)/benefit |
FEDERAL INCOME TAXES (Details 2
FEDERAL INCOME TAXES (Details 2) | Sep. 30, 2022 USD ($) |
Income Tax Disclosure [Abstract] | |
Net operating loss carryforward | $ 261,739 |
Capital loss carryforward | 6,084,731 |
Net unrealized losses (gains) on investment securities | 15,137,185 |
Total deferred tax assets | 21,483,655 |
Valuation allowance | (21,483,655) |
Net |
FEDERAL INCOME TAXES (Details 3
FEDERAL INCOME TAXES (Details 3) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |||||
Effective tax rate | 0% | 0% | 0% | 0% | |
Statutory federal income tax rate | 21% | 21% | 21% | 21% | 27.98% |
FEDERAL INCOME TAXES (Details 4
FEDERAL INCOME TAXES (Details 4) | 9 Months Ended |
Sep. 30, 2022 USD ($) | |
Tax Credit Carryforward [Line Items] | |
Capital loss carryforwards | $ 6,084,731 |
Capital Loss Carryforward 1 [Member] | |
Tax Credit Carryforward [Line Items] | |
EXPIRATION DATE | 12/31/24 |
Capital loss carryforwards | $ 14,230,073 |
Capital Loss Carryforward 2 [Member] | |
Tax Credit Carryforward [Line Items] | |
EXPIRATION DATE | 12/31/25 |
Capital loss carryforwards | $ 7,516,642 |
Capital Loss Carryforward [Member] | |
Tax Credit Carryforward [Line Items] | |
Capital loss carryforwards | $ 21,746,715 |
FEDERAL INCOME TAXES (Details N
FEDERAL INCOME TAXES (Details Narrative) - USD ($) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |||||
Statutory tax rate | 21% | ||||
State tax rate | 6.98% | ||||
Effective tax rate | 0% | ||||
State income tax | 21% | 21% | 21% | 21% | 27.98% |
Net operating loss carryforwards | $ 935,449 | ||||
Net capital loss carryforwards | 5 years |
INVESTMENT TRANSACTIONS (Detail
INVESTMENT TRANSACTIONS (Details) | 3 Months Ended |
Sep. 30, 2022 USD ($) | |
Investments, All Other Investments [Abstract] | |
Purchases of investment securities | $ 2,734 |
Proceeds from sales and maturities of investment securities | $ 5,307,261 |
SHARE BUYBACKS (Details Narrati
SHARE BUYBACKS (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands | 1 Months Ended | ||||||||||||||
Nov. 10, 2017 | Dec. 16, 2019 | Aug. 31, 2018 | Apr. 26, 2016 | Dec. 22, 2014 | Sep. 30, 2022 | Jun. 30, 2022 | Dec. 31, 2021 | Sep. 30, 2021 | Jun. 30, 2021 | Dec. 31, 2020 | Jun. 30, 2020 | Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2014 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||||||||||
Repurchased of shares | 272,008 | ||||||||||||||
Repurchased of shares value | $ 123,376 | $ 2,000 | |||||||||||||
Authorized to purchase | $ 2,000 | ||||||||||||||
Repurchased and retired shares | 128,551 | ||||||||||||||
Repurchased and retired shares value | $ 1,100 | ||||||||||||||
Shares outstanding | 6,893,056 | 6,893,056 | 6,893,056 | 6,893,056 | 6,893,056 | 6,893,056 | 6,893,056 | 7,178,770 | 7,302,146 | ||||||
Average price | $ 16.21 | ||||||||||||||
Common shares for cash | $ 20 | ||||||||||||||
Trading price | $ 23.2702 | ||||||||||||||
Tender offer description | Of the 5,044,728 shares properly tendered, the Fund purchased 859,468 shares of common stock pursuant to the tender offer. | ||||||||||||||
Tender offer | $ 2,000 | ||||||||||||||
Tender offer expired | Feb. 14, 2020 | ||||||||||||||
Purchase of shares | 285,714 | ||||||||||||||
Common stock price | $ 7 | ||||||||||||||
S V V C Stock [Member] | |||||||||||||||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||||||||||||||
Repurchased of shares value | $ 2,000 | ||||||||||||||
Total consideration amount | $ 2,000 |
INVESTMENTS IN AFFILIATES AND_3
INVESTMENTS IN AFFILIATES AND CONTROLLED INVESTMENTS (Details) | 9 Months Ended | |
Sep. 30, 2022 USD ($) shares | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | $ 59,744,294 | |
ENDING BALANCE | 42,408,025 | |
ENDING BALANCE | 42,408,025 | |
E Q X Capital Inc Common Stock [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 31,490 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (15,270) | [1] |
ENDING BALANCE | $ 16,220 | [1] |
SHARES HELD | shares | 100,000 | [1] |
SHARES HELD | shares | 100,000 | [1] |
ENDING BALANCE | $ 16,220 | [1] |
E Q X Capital Inc Series A Preferred Stock [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,898,420 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | (100,000) | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (614,600) | [1] |
ENDING BALANCE | $ 1,183,820 | [1] |
SHARES HELD | shares | 2,200,000 | [1] |
SHARES HELD | shares | 2,200,000 | [1] |
ENDING BALANCE | $ 1,183,820 | [1] |
Hera Systems Inc Convertible Note [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 40,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 3,533 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 40,000 | [1] |
SHARES HELD | shares | 40,000 | [1] |
SHARES HELD | shares | 40,000 | [1] |
ENDING BALANCE | $ 40,000 | [1] |
Hera Systems Inc Convertible Note 1 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 100,000 | [1] |
INTEREST | 2,222 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 100,000 | [1] |
SHARES HELD | shares | 100,000 | [1] |
SHARES HELD | shares | 100,000 | [1] |
ENDING BALANCE | $ 100,000 | [1] |
Hera Systems Inc Convertible Note 2 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 200,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 15,696 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 200,000 | [1] |
SHARES HELD | shares | 200,000 | [1] |
SHARES HELD | shares | 200,000 | [1] |
ENDING BALANCE | $ 200,000 | [1] |
Hera Systems Inc Convertible Note 3 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 55,000 | [1] |
INTEREST | 2,200 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 55,000 | [1] |
SHARES HELD | shares | 55,000 | [1] |
SHARES HELD | shares | 55,000 | [1] |
ENDING BALANCE | $ 55,000 | [1] |
Hera Systems Inc Convertible Note 4 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 150,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 12,334 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
Hera Systems Inc Convertible Note 5 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 150,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 12,626 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
Hera Systems Inc Convertible Note 6 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 150,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 11,527 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
Hera Systems Inc Convertible Note 7 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 70,000 | [1] |
INTEREST | 312 | [1] |
SALES/MATURITY/EXPIRATION | (70,000) | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 0 | [1] |
SHARES HELD | shares | 0 | [1] |
SHARES HELD | shares | 0 | [1] |
ENDING BALANCE | $ 0 | [1] |
Hera Systems Inc Convertible Note 8 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 150,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 11,375 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
Hera Systems Inc Convertible Note 9 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 150,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 11,375 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
Hera Systems Inc Convertible Note 10 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 150,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 11,375 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
Hera Systems Inc Convertible Note 11 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 150,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 11,658 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
Hera Systems Inc Convertible Note 12 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 90,000 | [1] |
INTEREST | 2,375 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 90,000 | [1] |
SHARES HELD | shares | 90,000 | [1] |
SHARES HELD | shares | 90,000 | [1] |
ENDING BALANCE | $ 90,000 | [1] |
Hera Systems Inc Convertible Note 13 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 200,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 17,306 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 200,000 | [1] |
SHARES HELD | shares | 200,000 | [1] |
SHARES HELD | shares | 200,000 | [1] |
ENDING BALANCE | $ 200,000 | [1] |
Hera Systems Inc Convertible Note 14 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 75,000 | [1] |
INTEREST | 2,354 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 75,000 | [1] |
SHARES HELD | shares | 75,000 | [1] |
SHARES HELD | shares | 75,000 | [1] |
ENDING BALANCE | $ 75,000 | [1] |
Hera Systems Inc Convertible Note 15 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 75,000 | [1] |
INTEREST | 3,292 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 75,000 | [1] |
SHARES HELD | shares | 75,000 | [1] |
SHARES HELD | shares | 75,000 | [1] |
ENDING BALANCE | $ 75,000 | [1] |
Hera Systems Inc Convertible Note 16 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 75,000 | [1] |
INTEREST | 2,667 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 75,000 | [1] |
SHARES HELD | shares | 75,000 | [1] |
SHARES HELD | shares | 75,000 | [1] |
ENDING BALANCE | $ 75,000 | [1] |
Hera Systems Inc Convertible Note 17 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 150,000 | [1] |
INTEREST | 9,708 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
Hera Systems Inc Convertible Note 18 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 500,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 52,986 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 500,000 | [1] |
SHARES HELD | shares | 500,000 | [1] |
SHARES HELD | shares | 500,000 | [1] |
ENDING BALANCE | $ 500,000 | [1] |
Hera Systems Inc Convertible Note 19 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 50,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 4,141 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 50,000 | [1] |
SHARES HELD | shares | 50,000 | [1] |
SHARES HELD | shares | 50,000 | [1] |
ENDING BALANCE | $ 50,000 | [1] |
Hera Systems Inc Convertible Note 20 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 150,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 12,038 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
Hera Systems Inc Convertible Note 21 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 150,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 12,178 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
Hera Systems Inc Convertible Note 22 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 70,000 | [1] |
INTEREST | 3,325 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 70,000 | [1] |
SHARES HELD | shares | 70,000 | [1] |
SHARES HELD | shares | 70,000 | [1] |
ENDING BALANCE | $ 70,000 | [1] |
Hera Systems Inc Convertible Note 23 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 250,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 20,881 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 250,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
ENDING BALANCE | $ 250,000 | [1] |
Hera Systems Inc Convertible Note 24 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 500,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 55,470 | [1] |
SALES/MATURITY/EXPIRATION | [1] | |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 500,000 | [1] |
SHARES HELD | shares | 500,000 | [1] |
SHARES HELD | shares | 500,000 | [1] |
ENDING BALANCE | $ 500,000 | [1] |
Hera Systems Inc Convertible Note 25 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 250,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 20,880 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 250,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
ENDING BALANCE | $ 250,000 | [1] |
Hera Systems Inc Convertible Note 26 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 250,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 22,369 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 250,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
ENDING BALANCE | $ 250,000 | [1] |
Hera Systems Inc Convertible Note 27 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 220,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 18,757 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 220,000 | [1] |
SHARES HELD | shares | 220,000 | [1] |
SHARES HELD | shares | 220,000 | [1] |
ENDING BALANCE | $ 220,000 | [1] |
Hera Systems Inc Convertible Note 28 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 20,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 1,748 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 20,000 | [1] |
SHARES HELD | shares | 20,000 | [1] |
SHARES HELD | shares | 20,000 | [1] |
ENDING BALANCE | $ 20,000 | [1] |
Hera Systems Inc Convertible Note 29 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 150,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 11,375 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | [1] | |
ENDING BALANCE | $ 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
Hera Systems Inc Convertible Note 30 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 90,000 | [1] |
INTEREST | 4,650 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 90,000 | [1] |
SHARES HELD | shares | 90,000 | [1] |
SHARES HELD | shares | 90,000 | [1] |
ENDING BALANCE | $ 90,000 | [1] |
Hera Systems Inc Convertible Note 31 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 75,000 | [1] |
INTEREST | 4,250 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 75,000 | [1] |
SHARES HELD | shares | 75,000 | [1] |
SHARES HELD | shares | 75,000 | [1] |
ENDING BALANCE | $ 75,000 | [1] |
Hera Systems Inc Convertible Note 32 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 250,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 20,881 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 250,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
ENDING BALANCE | $ 250,000 | [1] |
Hera Systems Inc Convertible Note 33 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 150,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 11,924 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 0 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
ENDING BALANCE | $ 150,000 | [1] |
Hera Systems Inc Series C Preferred [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 86,390 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 73,140 | [1] |
ENDING BALANCE | $ 159,530 | [1] |
SHARES HELD | shares | 2,650,000 | [1] |
SHARES HELD | shares | 2,650,000 | [1] |
ENDING BALANCE | $ 159,530 | [1] |
Hera Systems Inc Series A Preferred [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 8,377 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 5,464 | [1] |
ENDING BALANCE | $ 13,841 | [1] |
SHARES HELD | shares | 3,642,324 | [1] |
SHARES HELD | shares | 3,642,324 | [1] |
ENDING BALANCE | $ 13,841 | [1] |
Hera Systems Inc Series B Preferred [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 229,479 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 194,281 | [1] |
ENDING BALANCE | $ 423,760 | [1] |
SHARES HELD | shares | 7,039,203 | [1] |
SHARES HELD | shares | 7,039,203 | [1] |
ENDING BALANCE | $ 423,760 | [1] |
Hera Systems Inc Series B Warrants [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 202,296 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 171,469 | [1] |
ENDING BALANCE | $ 373,765 | [1] |
SHARES HELD | shares | 6,214,922 | [1] |
SHARES HELD | shares | 6,214,922 | [1] |
ENDING BALANCE | $ 373,765 | [1] |
Hera Systems Inc Series B Warrants 1 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 170,888 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 144,847 | [1] |
ENDING BALANCE | $ 315,735 | [1] |
SHARES HELD | shares | 5,250,000 | [1] |
SHARES HELD | shares | 5,250,000 | [1] |
ENDING BALANCE | $ 315,735 | [1] |
Hera Systems Inc Series B Warrants 2 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 22,785 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 19,313 | [1] |
ENDING BALANCE | $ 42,098 | [1] |
SHARES HELD | shares | 700,000 | [1] |
SHARES HELD | shares | 700,000 | [1] |
ENDING BALANCE | $ 42,098 | [1] |
Hera Systems Inc Series B Warrants 3 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 398,738 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 337,977 | [1] |
ENDING BALANCE | $ 736,715 | [1] |
SHARES HELD | shares | 12,250,000 | [1] |
SHARES HELD | shares | 12,250,000 | [1] |
ENDING BALANCE | $ 736,715 | [1] |
Intra Op Medical Corp Convertible Note [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,000,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (29,178) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (254,240) | [1] |
ENDING BALANCE | $ 745,760 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
ENDING BALANCE | $ 745,760 | [1] |
Intra Op Medical Corp Convertible Note 1 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 500,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (141,630) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (127,120) | [1] |
ENDING BALANCE | $ 372,880 | [1] |
SHARES HELD | shares | 500,000 | [1] |
SHARES HELD | shares | 500,000 | [1] |
ENDING BALANCE | $ 372,880 | [1] |
Intra Op Medical Corp Convertible Note 2 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,000,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (105,249) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (254,240) | [1] |
ENDING BALANCE | $ 745,760 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
ENDING BALANCE | $ 745,760 | [1] |
Intra Op Medical Corp Convertible Note 3 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 500,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (111,390) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (127,120) | [1] |
ENDING BALANCE | $ 372,880 | [1] |
SHARES HELD | shares | 500,000 | [1] |
SHARES HELD | shares | 500,000 | [1] |
ENDING BALANCE | $ 372,880 | [1] |
Intra Op Medical Corp Convertible Note 4 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 500,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (421) | |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (127,120) | [1] |
ENDING BALANCE | $ 372,880 | [1] |
SHARES HELD | shares | 500,000 | [1] |
SHARES HELD | shares | 500,000 | [1] |
ENDING BALANCE | $ 372,880 | [1] |
Intra Op Medical Corp Convertible Note 5 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 3,000,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 58,522 | |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (762,720) | [1] |
ENDING BALANCE | $ 2,237,280 | [1] |
SHARES HELD | shares | 3,000,000 | [1] |
SHARES HELD | shares | 3,000,000 | [1] |
ENDING BALANCE | $ 2,237,280 | [1] |
Intra Op Medical Corp Convertible Note 6 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,000,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (296,025) | |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (254,240) | [1] |
ENDING BALANCE | $ 745,760 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
ENDING BALANCE | $ 745,760 | [1] |
Intra Op Medical Corp Convertible Note 7 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 500,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (178,884) | |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (127,120) | [1] |
ENDING BALANCE | $ 372,880 | [1] |
SHARES HELD | shares | 500,000 | [1] |
SHARES HELD | shares | 500,000 | [1] |
ENDING BALANCE | $ 372,880 | [1] |
Intra Op Medical Corp Convertible Note 8 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 10,961,129 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (5,721,295) | |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (2,786,757) | [1] |
ENDING BALANCE | $ 8,174,372 | [1] |
SHARES HELD | shares | 10,961,129 | [1] |
SHARES HELD | shares | 10,961,129 | [1] |
ENDING BALANCE | $ 8,174,372 | [1] |
Intra Op Medical Corp Convertible Note 9 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,300,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (542,140) | |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (330,512) | [1] |
ENDING BALANCE | $ 969,488 | [1] |
SHARES HELD | shares | 1,300,000 | [1] |
SHARES HELD | shares | 1,300,000 | [1] |
ENDING BALANCE | $ 969,488 | [1] |
Intra Op Medical Corp Convertible Note 10 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 500,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (183,777) | |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (127,120) | [1] |
ENDING BALANCE | $ 372,880 | [1] |
SHARES HELD | shares | 500,000 | [1] |
SHARES HELD | shares | 500,000 | [1] |
ENDING BALANCE | $ 372,880 | [1] |
Intra Op Medical Corp Convertible Note 11 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 500,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (34,726) | |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (127,120) | [1] |
ENDING BALANCE | $ 372,880 | [1] |
SHARES HELD | shares | 500,000 | [1] |
SHARES HELD | shares | 500,000 | [1] |
ENDING BALANCE | $ 372,880 | [1] |
Intra Op Medical Corp Convertible Note 12 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 350,000 | [1] |
INTEREST | 0 | |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (88,984) | [1] |
ENDING BALANCE | $ 261,016 | [1] |
SHARES HELD | shares | 350,000 | [1] |
SHARES HELD | shares | 350,000 | [1] |
ENDING BALANCE | $ 261,016 | [1] |
Intra Op Medical Corp Convertible Note 13 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 700,000 | [1] |
INTEREST | 0 | |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (177,968) | [1] |
ENDING BALANCE | $ 522,032 | [1] |
SHARES HELD | shares | 700,000 | [1] |
SHARES HELD | shares | 700,000 | [1] |
ENDING BALANCE | $ 522,032 | [1] |
Intra Op Medical Corp Convertible Note 14 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 500,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (20,753) | |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (127,120) | [1] |
ENDING BALANCE | $ 372,880 | [1] |
SHARES HELD | shares | 500,000 | [1] |
SHARES HELD | shares | 500,000 | [1] |
ENDING BALANCE | $ 372,880 | [1] |
Intra Op Medical Corp Convertible Note 15 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 500,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (17,877) | |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (127,120) | [1] |
ENDING BALANCE | $ 372,880 | [1] |
SHARES HELD | shares | 500,000 | [1] |
SHARES HELD | shares | 500,000 | [1] |
ENDING BALANCE | $ 372,880 | [1] |
Intra Op Medical Corp Convertible Note 16 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 150,000 | [1] |
INTEREST | 0 | |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (38,136) | [1] |
ENDING BALANCE | $ 111,864 | [1] |
SHARES HELD | shares | 150,000 | [1] |
SHARES HELD | shares | 150,000 | [1] |
ENDING BALANCE | $ 111,864 | [1] |
Intra Op Medical Corp Convertible Note 17 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 500,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (6,781) | |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (127,120) | [1] |
ENDING BALANCE | $ 372,880 | [1] |
SHARES HELD | shares | 500,000 | [1] |
SHARES HELD | shares | 500,000 | [1] |
ENDING BALANCE | $ 372,880 | [1] |
Intra Op Medical Corp Convertible Note 18 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 200,000 | [1] |
INTEREST | 0 | |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (50,848) | [1] |
ENDING BALANCE | $ 149,152 | [1] |
SHARES HELD | shares | 200,000 | [1] |
SHARES HELD | shares | 200,000 | [1] |
ENDING BALANCE | $ 149,152 | [1] |
Intra Op Medical Corp Convertible Note 19 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 500,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (10,274) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (127,120) | [1] |
ENDING BALANCE | $ 372,880 | [1] |
SHARES HELD | shares | 500,000 | [1] |
SHARES HELD | shares | 500,000 | [1] |
ENDING BALANCE | $ 372,880 | [1] |
Intra Op Medical Corp Convertible Note 20 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 400,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (104,983) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (101,696) | [1] |
ENDING BALANCE | $ 298,304 | [1] |
SHARES HELD | shares | 400,000 | [1] |
SHARES HELD | shares | 400,000 | [1] |
ENDING BALANCE | $ 298,304 | [1] |
Intra Op Medical Corp Convertible Note 21 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 750,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (157,131) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (190,680) | [1] |
ENDING BALANCE | $ 559,320 | [1] |
SHARES HELD | shares | 750,000 | [1] |
SHARES HELD | shares | 750,000 | [1] |
ENDING BALANCE | $ 559,320 | [1] |
Intra Op Medical Corp Series C Preferred [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 670,062 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (670,062) | [1] |
ENDING BALANCE | [1] | |
SHARES HELD | shares | 26,856,187 | [1] |
SHARES HELD | shares | 26,856,187 | [1] |
ENDING BALANCE | [1] | |
Intra Op Medical Corp Term Note [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 2,000,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 39,452 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (508,480) | [1] |
ENDING BALANCE | $ 1,491,520 | [1] |
SHARES HELD | shares | 2,000,000 | [1] |
SHARES HELD | shares | 2,000,000 | [1] |
ENDING BALANCE | $ 1,491,520 | [1] |
Pivotal Systems Corp C D I [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 9,287,771 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | (2,107,070) | [1] |
REALIZED GAIN (LOSS) | 2,097,196 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (9,277,897) | [1] |
ENDING BALANCE | $ 0 | [1] |
SHARES HELD | shares | 0 | [1] |
SHARES HELD | shares | 0 | [1] |
ENDING BALANCE | $ 0 | [1] |
Revasum Inc C D I [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 21,466,824 | [1] |
PURCHASE/MERGER | 2,735 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | (3,100,196) | [1] |
REALIZED GAIN (LOSS) | (1,146,583) | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (14,169,739) | [1] |
ENDING BALANCE | $ 3,053,041 | [1] |
SHARES HELD | shares | 39,774,889 | [1] |
SHARES HELD | shares | 39,774,889 | [1] |
ENDING BALANCE | $ 3,053,041 | [1] |
Silicon Genesis Corp Common Stock [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 277 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (166) | [1] |
ENDING BALANCE | $ 111 | [1] |
SHARES HELD | shares | 921,892 | [1] |
SHARES HELD | shares | 921,892 | [1] |
ENDING BALANCE | $ 111 | [1] |
Silicon Genesis Corp Common Warrants [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 3 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (2) | [1] |
ENDING BALANCE | $ 1 | [1] |
SHARES HELD | shares | 37,982 | [1] |
SHARES HELD | shares | 37,982 | [1] |
ENDING BALANCE | $ 1 | [1] |
Silicon Genesis Corp Series 1 D Preferred [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 5,275 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (2,637) | [1] |
ENDING BALANCE | $ 2,638 | [1] |
SHARES HELD | shares | 850,830 | [1] |
SHARES HELD | shares | 850,830 | [1] |
ENDING BALANCE | $ 2,638 | [1] |
Silicon Genesis Corp Series 1 F Preferred [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 100,187 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (28,194) | [1] |
ENDING BALANCE | $ 71,993 | [1] |
SHARES HELD | shares | 912,453 | [1] |
SHARES HELD | shares | 912,453 | [1] |
ENDING BALANCE | $ 71,993 | [1] |
Silicon Genesis Corp Series 1 G Preferred [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 439,206 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (126,731) | [1] |
ENDING BALANCE | $ 312,475 | [1] |
SHARES HELD | shares | 48,370,793 | [1] |
SHARES HELD | shares | 48,370,793 | [1] |
ENDING BALANCE | $ 312,475 | [1] |
Silicon Genesis Corp Series 1 H Preferred [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 50,277 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (14,162) | [1] |
ENDING BALANCE | $ 36,115 | [1] |
SHARES HELD | shares | 837,942 | [1] |
SHARES HELD | shares | 837,942 | [1] |
ENDING BALANCE | $ 36,115 | [1] |
Silicon Genesis Corp Series 1 E Preferred [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 453,506 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (127,210) | [1] |
ENDING BALANCE | $ 326,296 | [1] |
SHARES HELD | shares | 5,704,480 | [1] |
SHARES HELD | shares | 5,704,480 | [1] |
ENDING BALANCE | $ 326,296 | [1] |
Silicon Genesis Corp Series 1 C Preferred Stock [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,990 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (970) | [1] |
ENDING BALANCE | $ 1,020 | [1] |
SHARES HELD | shares | 82,914 | [1] |
SHARES HELD | shares | 82,914 | [1] |
ENDING BALANCE | $ 1,020 | [1] |
S V X R Inc Series A Preferred Stock [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | (4,082,192) | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | 4,082,192 | [1] |
ENDING BALANCE | $ 0 | [1] |
SHARES HELD | shares | 0 | [1] |
SHARES HELD | shares | 0 | [1] |
ENDING BALANCE | $ 0 | [1] |
U C T Coatings Inc Common Stock [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 613,650 | |
PURCHASE/MERGER | 0 | |
INTEREST | 0 | |
SALES/MATURITY/EXPIRATION | 0 | |
REALIZED GAIN (LOSS) | 0 | |
CHANGE IN APPRECIATION/(DEPRECIATION) | (234,000) | |
ENDING BALANCE | $ 379,650 | |
SHARES HELD | shares | 1,500,000 | |
SHARES HELD | shares | 1,500,000 | |
ENDING BALANCE | $ 379,650 | |
Wrightspeed Inc Common Stock [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,126 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (559) | [1] |
ENDING BALANCE | $ 567 | [1] |
SHARES HELD | shares | 69,102 | [1] |
SHARES HELD | shares | 69,102 | [1] |
ENDING BALANCE | $ 567 | [1] |
Wrightspeed Inc Convertible Note [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 300,000 | [1] |
PURCHASE/MERGER | [1] | |
INTEREST | (10,100) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (162,000) | [1] |
ENDING BALANCE | $ 138,000 | [1] |
SHARES HELD | shares | 300,000 | [1] |
SHARES HELD | shares | 300,000 | [1] |
ENDING BALANCE | $ 138,000 | [1] |
Wrightspeed Inc Convertible Note 1 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 400,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (51,807) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (216,000) | [1] |
ENDING BALANCE | $ 184,000 | [1] |
SHARES HELD | shares | 400,000 | [1] |
SHARES HELD | shares | 400,000 | [1] |
ENDING BALANCE | $ 184,000 | [1] |
Wrightspeed Inc Convertible Note 2 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,000,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (24,333) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (540,000) | [1] |
ENDING BALANCE | $ 460,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
ENDING BALANCE | $ 460,000 | [1] |
Wrightspeed Inc Convertible Note 3 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,000,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (13,000) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (540,000) | [1] |
ENDING BALANCE | $ 460,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
ENDING BALANCE | $ 460,000 | [1] |
Wrightspeed Inc Convertible Note 4 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,000,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (1,333) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (540,000) | [1] |
ENDING BALANCE | $ 460,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
ENDING BALANCE | $ 460,000 | [1] |
Wrightspeed Inc Convertible Note 5 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 700,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (20,533) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (378,000) | [1] |
ENDING BALANCE | $ 322,000 | [1] |
SHARES HELD | shares | 700,000 | [1] |
SHARES HELD | shares | 700,000 | [1] |
ENDING BALANCE | $ 322,000 | [1] |
Wrightspeed Inc Convertible Note 6 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 200,000 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (108,000) | [1] |
ENDING BALANCE | $ 92,000 | [1] |
SHARES HELD | shares | 200,000 | [1] |
SHARES HELD | shares | 200,000 | [1] |
ENDING BALANCE | $ 92,000 | [1] |
Wrightspeed Inc Convertible Note 7 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 185,000 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (99,900) | [1] |
ENDING BALANCE | $ 85,100 | [1] |
SHARES HELD | shares | 185,000 | [1] |
SHARES HELD | shares | 185,000 | [1] |
ENDING BALANCE | $ 85,100 | [1] |
Wrightspeed Inc Convertible Note 8 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,400,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (145,600) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (756,000) | [1] |
ENDING BALANCE | $ 644,000 | [1] |
SHARES HELD | shares | 1,400,000 | [1] |
SHARES HELD | shares | 1,400,000 | [1] |
ENDING BALANCE | $ 644,000 | [1] |
Wrightspeed Inc Convertible Note 9 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,200,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (105,600) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (648,000) | [1] |
ENDING BALANCE | $ 552,000 | [1] |
SHARES HELD | shares | 1,200,000 | [1] |
SHARES HELD | shares | 1,200,000 | [1] |
ENDING BALANCE | $ 552,000 | [1] |
Wrightspeed Inc Convertible Note 10 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,000,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (76,000) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (540,000) | [1] |
ENDING BALANCE | $ 460,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
ENDING BALANCE | $ 460,000 | [1] |
Wrightspeed Inc Convertible Note 11 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,000,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (64,355) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (540,000) | [1] |
ENDING BALANCE | $ 460,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
ENDING BALANCE | $ 460,000 | [1] |
Wrightspeed Inc Convertible Note 12 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,000,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (53,000) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (540,000) | [1] |
ENDING BALANCE | $ 460,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
ENDING BALANCE | $ 460,000 | [1] |
Wrightspeed Inc Convertible Note 13 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,050,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (159,157) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (567,000) | [1] |
ENDING BALANCE | $ 483,000 | [1] |
SHARES HELD | shares | 1,050,000 | [1] |
SHARES HELD | shares | 1,050,000 | [1] |
ENDING BALANCE | $ 483,000 | [1] |
Wrightspeed Inc Convertible Note 14 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 400,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (56,294) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (216,000) | [1] |
ENDING BALANCE | $ 184,000 | [1] |
SHARES HELD | shares | 400,000 | [1] |
SHARES HELD | shares | 400,000 | [1] |
ENDING BALANCE | $ 184,000 | [1] |
Wrightspeed Inc Convertible Note 15 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 900,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (147,525) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (486,000) | [1] |
ENDING BALANCE | $ 414,000 | [1] |
SHARES HELD | shares | 900,000 | [1] |
SHARES HELD | shares | 900,000 | [1] |
ENDING BALANCE | $ 414,000 | [1] |
Wrightspeed Inc Convertible Note 16 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,000,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (45,000) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (540,000) | [1] |
ENDING BALANCE | $ 460,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
SHARES HELD | shares | 1,000,000 | [1] |
ENDING BALANCE | $ 460,000 | [1] |
Wrightspeed Inc Convertible Note 17 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 750,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (131,069) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (405,000) | [1] |
ENDING BALANCE | $ 345,000 | [1] |
SHARES HELD | shares | 750,000 | [1] |
SHARES HELD | shares | 750,000 | [1] |
ENDING BALANCE | $ 345,000 | [1] |
Wrightspeed Inc Convertible Note 18 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 4,929,015 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (1,625,767) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (2,661,668) | [1] |
ENDING BALANCE | $ 2,267,347 | [1] |
SHARES HELD | shares | 4,929,015 | [1] |
SHARES HELD | shares | 4,929,015 | [1] |
ENDING BALANCE | $ 2,267,347 | [1] |
Wrightspeed Inc Convertible Note 19 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 65,000 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (35,100) | [1] |
ENDING BALANCE | $ 29,900 | [1] |
SHARES HELD | shares | 65,000 | [1] |
SHARES HELD | shares | 65,000 | [1] |
ENDING BALANCE | $ 29,900 | [1] |
Wrightspeed Inc Convertible Note 20 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 250,000 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (135,000) | [1] |
ENDING BALANCE | $ 115,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
ENDING BALANCE | $ 115,000 | [1] |
Wrightspeed Inc Convertible Note 21 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 250,000 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (135,000) | [1] |
ENDING BALANCE | $ 115,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
ENDING BALANCE | $ 115,000 | [1] |
Wrightspeed Inc Convertible Note 22 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 250,000 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (135,000) | [1] |
ENDING BALANCE | $ 115,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
ENDING BALANCE | $ 115,000 | [1] |
Wrightspeed Inc Convertible Note 23 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 250,000 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (135,000) | [1] |
ENDING BALANCE | $ 115,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
ENDING BALANCE | $ 115,000 | [1] |
Wrightspeed Inc Convertible Note 24 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 250,000 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (135,000) | [1] |
ENDING BALANCE | $ 115,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
ENDING BALANCE | $ 115,000 | [1] |
Wrightspeed Inc Convertible Note 25 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 0 | [1] |
PURCHASE/MERGER | 250,000 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (135,000) | [1] |
ENDING BALANCE | $ 115,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
SHARES HELD | shares | 250,000 | [1] |
ENDING BALANCE | $ 115,000 | [1] |
Wrightspeed Inc Convertible Note 26 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 375,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (50,813) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (202,500) | [1] |
ENDING BALANCE | $ 172,500 | [1] |
SHARES HELD | shares | 375,000 | [1] |
SHARES HELD | shares | 375,000 | [1] |
ENDING BALANCE | $ 172,500 | [1] |
Wrightspeed Inc Convertible Note 27 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 2,000,000 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | (250,063) | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (1,080,000) | [1] |
ENDING BALANCE | $ 920,000 | [1] |
SHARES HELD | shares | 2,000,000 | [1] |
SHARES HELD | shares | 2,000,000 | [1] |
ENDING BALANCE | $ 920,000 | [1] |
Wrightspeed Inc Convertible Note 28 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 1,777,068 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (702,082) | [1] |
ENDING BALANCE | $ 1,074,986 | [1] |
SHARES HELD | shares | 60,733,693 | [1] |
SHARES HELD | shares | 60,733,693 | [1] |
ENDING BALANCE | $ 1,074,986 | [1] |
Wrightspeed Inc Convertible Note 29 [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 7,500 | [1] |
PURCHASE/MERGER | 0 | [1] |
INTEREST | 0 | [1] |
SALES/MATURITY/EXPIRATION | 0 | [1] |
REALIZED GAIN (LOSS) | 0 | [1] |
CHANGE IN APPRECIATION/(DEPRECIATION) | (4,086) | [1] |
ENDING BALANCE | $ 3,414 | [1] |
SHARES HELD | shares | 609,756 | [1] |
SHARES HELD | shares | 609,756 | [1] |
ENDING BALANCE | $ 3,414 | [1] |
Total Affiliates And Controlled Investments [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 90,118,729 | [1] |
INTEREST | (10,174,101) | |
REALIZED GAIN (LOSS) | (3,131,579) | |
CHANGE IN APPRECIATION/(DEPRECIATION) | (40,776,553) | |
ENDING BALANCE | 45,361,066 | |
ENDING BALANCE | 45,361,066 | |
Affiliates [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 613,650 | |
INTEREST | ||
REALIZED GAIN (LOSS) | (4,082,192) | |
CHANGE IN APPRECIATION/(DEPRECIATION) | 3,848,192 | |
ENDING BALANCE | 379,650 | |
ENDING BALANCE | 379,650 | |
Controlled Investments [Member] | ||
Net Investment Income [Line Items] | ||
BEGINNING BALANCE | 89,505,079 | |
INTEREST | (10,174,101) | |
REALIZED GAIN (LOSS) | 950,613 | |
CHANGE IN APPRECIATION/(DEPRECIATION) | (44,624,745) | |
ENDING BALANCE | 44,981,416 | |
ENDING BALANCE | $ 44,981,416 | |
[1]Controlled Investments. |